CA2629555A1 - Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures - Google Patents
Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures Download PDFInfo
- Publication number
- CA2629555A1 CA2629555A1 CA002629555A CA2629555A CA2629555A1 CA 2629555 A1 CA2629555 A1 CA 2629555A1 CA 002629555 A CA002629555 A CA 002629555A CA 2629555 A CA2629555 A CA 2629555A CA 2629555 A1 CA2629555 A1 CA 2629555A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- stem cells
- bacteria
- cell
- microbes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000009313 farming Methods 0.000 title claims description 8
- 230000036541 health Effects 0.000 title claims description 7
- 210000000130 stem cell Anatomy 0.000 claims description 170
- 210000004027 cell Anatomy 0.000 claims description 149
- 210000000988 bone and bone Anatomy 0.000 claims description 101
- 108090000623 proteins and genes Proteins 0.000 claims description 83
- 238000000034 method Methods 0.000 claims description 79
- 241000894006 Bacteria Species 0.000 claims description 57
- 210000001519 tissue Anatomy 0.000 claims description 49
- 239000000463 material Substances 0.000 claims description 47
- 229920001661 Chitosan Polymers 0.000 claims description 45
- 102000004169 proteins and genes Human genes 0.000 claims description 45
- 239000000047 product Substances 0.000 claims description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 38
- 108020004414 DNA Proteins 0.000 claims description 37
- 229910052751 metal Inorganic materials 0.000 claims description 37
- 239000002184 metal Substances 0.000 claims description 37
- 102000004190 Enzymes Human genes 0.000 claims description 35
- 108090000790 Enzymes Proteins 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 238000011160 research Methods 0.000 claims description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- 201000010099 disease Diseases 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 31
- 206010028980 Neoplasm Diseases 0.000 claims description 29
- 241000282414 Homo sapiens Species 0.000 claims description 27
- 230000035755 proliferation Effects 0.000 claims description 26
- 210000003608 fece Anatomy 0.000 claims description 25
- 230000012010 growth Effects 0.000 claims description 25
- 230000008569 process Effects 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 25
- 229910001385 heavy metal Inorganic materials 0.000 claims description 24
- 231100000765 toxin Toxicity 0.000 claims description 24
- 239000003053 toxin Substances 0.000 claims description 24
- 108700012359 toxins Proteins 0.000 claims description 24
- 150000002739 metals Chemical class 0.000 claims description 22
- 241000894007 species Species 0.000 claims description 22
- 238000010367 cloning Methods 0.000 claims description 20
- 230000008901 benefit Effects 0.000 claims description 19
- 230000001965 increasing effect Effects 0.000 claims description 19
- 239000010871 livestock manure Substances 0.000 claims description 19
- 210000002784 stomach Anatomy 0.000 claims description 19
- 210000001185 bone marrow Anatomy 0.000 claims description 18
- 239000011575 calcium Substances 0.000 claims description 18
- 235000015097 nutrients Nutrition 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 18
- 239000013589 supplement Substances 0.000 claims description 18
- 229910052791 calcium Inorganic materials 0.000 claims description 17
- 201000011510 cancer Diseases 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 17
- 235000013305 food Nutrition 0.000 claims description 17
- 210000000515 tooth Anatomy 0.000 claims description 17
- 241000283690 Bos taurus Species 0.000 claims description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 16
- 240000008042 Zea mays Species 0.000 claims description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 16
- 230000008468 bone growth Effects 0.000 claims description 16
- 235000005822 corn Nutrition 0.000 claims description 16
- 210000000805 cytoplasm Anatomy 0.000 claims description 16
- 210000003414 extremity Anatomy 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- -1 Pro aromatic Trp Chemical compound 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 15
- 108020003175 receptors Proteins 0.000 claims description 15
- 102000005962 receptors Human genes 0.000 claims description 15
- 210000002421 cell wall Anatomy 0.000 claims description 14
- 210000002865 immune cell Anatomy 0.000 claims description 14
- 150000003839 salts Chemical class 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 13
- 210000004556 brain Anatomy 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 239000003102 growth factor Substances 0.000 claims description 13
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 241000282412 Homo Species 0.000 claims description 12
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 12
- 244000061456 Solanum tuberosum Species 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 230000004060 metabolic process Effects 0.000 claims description 12
- 239000010865 sewage Substances 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 238000011161 development Methods 0.000 claims description 11
- 230000018109 developmental process Effects 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 11
- 230000037361 pathway Effects 0.000 claims description 11
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 230000004663 cell proliferation Effects 0.000 claims description 10
- 210000004379 membrane Anatomy 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 239000010815 organic waste Substances 0.000 claims description 10
- 239000000123 paper Substances 0.000 claims description 10
- 230000035939 shock Effects 0.000 claims description 10
- 244000269722 Thea sinensis Species 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000002560 therapeutic procedure Methods 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 8
- 230000005754 cellular signaling Effects 0.000 claims description 8
- 230000001684 chronic effect Effects 0.000 claims description 8
- 235000005911 diet Nutrition 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 210000002381 plasma Anatomy 0.000 claims description 8
- 235000012015 potatoes Nutrition 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000002699 waste material Substances 0.000 claims description 8
- 208000030507 AIDS Diseases 0.000 claims description 7
- 108010035532 Collagen Proteins 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 7
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 7
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 7
- 108700020796 Oncogene Proteins 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 230000014509 gene expression Effects 0.000 claims description 7
- 238000001727 in vivo Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 7
- 201000006417 multiple sclerosis Diseases 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 244000052769 pathogen Species 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 239000011435 rock Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 230000035882 stress Effects 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 6
- 241000238017 Astacoidea Species 0.000 claims description 6
- 241000270722 Crocodylidae Species 0.000 claims description 6
- 241000086550 Dinosauria Species 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 6
- 230000037213 diet Effects 0.000 claims description 6
- 230000005611 electricity Effects 0.000 claims description 6
- 239000006260 foam Substances 0.000 claims description 6
- 239000013505 freshwater Substances 0.000 claims description 6
- 230000035876 healing Effects 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 5
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 5
- 208000018737 Parkinson disease Diseases 0.000 claims description 5
- 108091000080 Phosphotransferase Proteins 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
- 230000015556 catabolic process Effects 0.000 claims description 5
- 239000002361 compost Substances 0.000 claims description 5
- 230000006378 damage Effects 0.000 claims description 5
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 229940088597 hormone Drugs 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 230000035800 maturation Effects 0.000 claims description 5
- 230000003278 mimic effect Effects 0.000 claims description 5
- 239000010813 municipal solid waste Substances 0.000 claims description 5
- 210000003463 organelle Anatomy 0.000 claims description 5
- 102000020233 phosphotransferase Human genes 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000009467 reduction Effects 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 208000024827 Alzheimer disease Diseases 0.000 claims description 4
- 208000035143 Bacterial infection Diseases 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims description 4
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims description 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 210000003169 central nervous system Anatomy 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000013522 chelant Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 208000037976 chronic inflammation Diseases 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 230000005484 gravity Effects 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 230000011664 signaling Effects 0.000 claims description 4
- 230000008733 trauma Effects 0.000 claims description 4
- 201000001320 Atherosclerosis Diseases 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 3
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 claims description 3
- 241000238557 Decapoda Species 0.000 claims description 3
- 241000221089 Jatropha Species 0.000 claims description 3
- 206010025323 Lymphomas Diseases 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 206010003246 arthritis Diseases 0.000 claims description 3
- 210000002805 bone matrix Anatomy 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 230000006020 chronic inflammation Effects 0.000 claims description 3
- 230000001086 cytosolic effect Effects 0.000 claims description 3
- 230000003111 delayed effect Effects 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 239000010432 diamond Substances 0.000 claims description 3
- 229920001971 elastomer Polymers 0.000 claims description 3
- 210000004602 germ cell Anatomy 0.000 claims description 3
- 239000000122 growth hormone Substances 0.000 claims description 3
- 208000032839 leukemia Diseases 0.000 claims description 3
- 210000003716 mesoderm Anatomy 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940053128 nerve growth factor Drugs 0.000 claims description 3
- 230000004770 neurodegeneration Effects 0.000 claims description 3
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 3
- 210000000287 oocyte Anatomy 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 230000001717 pathogenic effect Effects 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000000902 placebo Substances 0.000 claims description 3
- 229940068196 placebo Drugs 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 230000000306 recurrent effect Effects 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 claims description 3
- 238000011069 regeneration method Methods 0.000 claims description 3
- 239000005060 rubber Substances 0.000 claims description 3
- 235000015170 shellfish Nutrition 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 229940034610 toothpaste Drugs 0.000 claims description 3
- 239000000606 toothpaste Substances 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 208000020222 Acanthamoeba infectious disease Diseases 0.000 claims description 2
- 208000004881 Amebiasis Diseases 0.000 claims description 2
- 206010006448 Bronchiolitis Diseases 0.000 claims description 2
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 206010012289 Dementia Diseases 0.000 claims description 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 206010024639 Listeria infections Diseases 0.000 claims description 2
- 206010024641 Listeriosis Diseases 0.000 claims description 2
- 208000019693 Lung disease Diseases 0.000 claims description 2
- 102000029749 Microtubule Human genes 0.000 claims description 2
- 108091022875 Microtubule Proteins 0.000 claims description 2
- 208000012902 Nervous system disease Diseases 0.000 claims description 2
- 208000036110 Neuroinflammatory disease Diseases 0.000 claims description 2
- 208000025966 Neurological disease Diseases 0.000 claims description 2
- 208000012868 Overgrowth Diseases 0.000 claims description 2
- 208000024777 Prion disease Diseases 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 2
- 206010040047 Sepsis Diseases 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 208000007536 Thrombosis Diseases 0.000 claims description 2
- 241000223997 Toxoplasma gondii Species 0.000 claims description 2
- 102000004243 Tubulin Human genes 0.000 claims description 2
- 108090000704 Tubulin Proteins 0.000 claims description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 2
- 208000021240 acute bronchiolitis Diseases 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 201000002816 chronic venous insufficiency Diseases 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 238000002591 computed tomography Methods 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 235000021186 dishes Nutrition 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 230000003176 fibrotic effect Effects 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 230000000977 initiatory effect Effects 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 208000017169 kidney disease Diseases 0.000 claims description 2
- 210000000265 leukocyte Anatomy 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 208000002780 macular degeneration Diseases 0.000 claims description 2
- 210000000274 microglia Anatomy 0.000 claims description 2
- 210000004688 microtubule Anatomy 0.000 claims description 2
- 239000002324 mouth wash Substances 0.000 claims description 2
- 229940051866 mouthwash Drugs 0.000 claims description 2
- 230000003959 neuroinflammation Effects 0.000 claims description 2
- 238000010899 nucleation Methods 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 230000001172 regenerating effect Effects 0.000 claims description 2
- 208000037803 restenosis Diseases 0.000 claims description 2
- 210000003625 skull Anatomy 0.000 claims description 2
- 239000003104 tissue culture media Substances 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 230000032258 transport Effects 0.000 claims description 2
- 230000002792 vascular Effects 0.000 claims description 2
- 201000002282 venous insufficiency Diseases 0.000 claims description 2
- 210000000707 wrist Anatomy 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 claims 46
- 235000018291 probiotics Nutrition 0.000 claims 46
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 41
- 229910052753 mercury Inorganic materials 0.000 claims 41
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 39
- 230000000529 probiotic effect Effects 0.000 claims 35
- 210000004185 liver Anatomy 0.000 claims 34
- 229940088598 enzyme Drugs 0.000 claims 33
- 235000018102 proteins Nutrition 0.000 claims 26
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 24
- 108700005087 Homeobox Genes Proteins 0.000 claims 23
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 claims 19
- 229960003180 glutathione Drugs 0.000 claims 19
- 210000000056 organ Anatomy 0.000 claims 19
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims 18
- 210000003205 muscle Anatomy 0.000 claims 18
- 230000002062 proliferating effect Effects 0.000 claims 18
- 108010024636 Glutathione Proteins 0.000 claims 17
- 229960004452 methionine Drugs 0.000 claims 17
- 229910052717 sulfur Inorganic materials 0.000 claims 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 16
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 16
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 16
- 235000013601 eggs Nutrition 0.000 claims 16
- 210000000987 immune system Anatomy 0.000 claims 16
- 235000013406 prebiotics Nutrition 0.000 claims 16
- 239000011593 sulfur Substances 0.000 claims 16
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 15
- 210000003899 penis Anatomy 0.000 claims 15
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 14
- 230000009286 beneficial effect Effects 0.000 claims 14
- 229960002433 cysteine Drugs 0.000 claims 14
- 230000002068 genetic effect Effects 0.000 claims 14
- 210000001865 kupffer cell Anatomy 0.000 claims 14
- 241000186000 Bifidobacterium Species 0.000 claims 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 13
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 13
- 235000018417 cysteine Nutrition 0.000 claims 13
- 229930182817 methionine Natural products 0.000 claims 13
- 239000002243 precursor Substances 0.000 claims 13
- 231100000331 toxic Toxicity 0.000 claims 13
- 230000002588 toxic effect Effects 0.000 claims 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 12
- 230000000968 intestinal effect Effects 0.000 claims 12
- 229940024606 amino acid Drugs 0.000 claims 11
- 235000001014 amino acid Nutrition 0.000 claims 11
- 239000003963 antioxidant agent Substances 0.000 claims 11
- 230000003078 antioxidant effect Effects 0.000 claims 11
- 235000013330 chicken meat Nutrition 0.000 claims 11
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 11
- 210000002700 urine Anatomy 0.000 claims 11
- 239000002551 biofuel Substances 0.000 claims 10
- 239000001913 cellulose Substances 0.000 claims 10
- 229920002678 cellulose Polymers 0.000 claims 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 10
- 210000000936 intestine Anatomy 0.000 claims 10
- JLVSRWOIZZXQAD-UHFFFAOYSA-N 2,3-disulfanylpropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(S)CS JLVSRWOIZZXQAD-UHFFFAOYSA-N 0.000 claims 9
- 240000007154 Coffea arabica Species 0.000 claims 9
- 241000256602 Isoptera Species 0.000 claims 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 9
- 235000006708 antioxidants Nutrition 0.000 claims 9
- 210000002459 blastocyst Anatomy 0.000 claims 9
- 230000029142 excretion Effects 0.000 claims 9
- 210000003754 fetus Anatomy 0.000 claims 9
- 210000002569 neuron Anatomy 0.000 claims 9
- 230000035807 sensation Effects 0.000 claims 9
- 239000000829 suppository Substances 0.000 claims 9
- 229910052725 zinc Inorganic materials 0.000 claims 9
- 239000011701 zinc Substances 0.000 claims 9
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 claims 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 8
- 230000007246 mechanism Effects 0.000 claims 8
- 229910000497 Amalgam Inorganic materials 0.000 claims 7
- WMTIOGUVKBSEOW-UHFFFAOYSA-N ClC1(Cl)OP(=O)OP(=O)O1 Chemical compound ClC1(Cl)OP(=O)OP(=O)O1 WMTIOGUVKBSEOW-UHFFFAOYSA-N 0.000 claims 7
- 241000192700 Cyanobacteria Species 0.000 claims 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 7
- 241000186660 Lactobacillus Species 0.000 claims 7
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims 7
- 210000001072 colon Anatomy 0.000 claims 7
- 208000035475 disorder Diseases 0.000 claims 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 7
- 238000001990 intravenous administration Methods 0.000 claims 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 7
- 210000002540 macrophage Anatomy 0.000 claims 7
- 239000011707 mineral Substances 0.000 claims 7
- 230000004044 response Effects 0.000 claims 7
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims 7
- 229960004245 silymarin Drugs 0.000 claims 7
- 235000017700 silymarin Nutrition 0.000 claims 7
- 208000024891 symptom Diseases 0.000 claims 7
- 241001430294 unidentified retrovirus Species 0.000 claims 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 6
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 6
- 102000009331 Homeodomain Proteins Human genes 0.000 claims 6
- 108010048671 Homeodomain Proteins Proteins 0.000 claims 6
- 240000001046 Lactobacillus acidophilus Species 0.000 claims 6
- 235000010841 Silybum marianum Nutrition 0.000 claims 6
- 230000003416 augmentation Effects 0.000 claims 6
- 230000003115 biocidal effect Effects 0.000 claims 6
- 238000001784 detoxification Methods 0.000 claims 6
- 238000001415 gene therapy Methods 0.000 claims 6
- 239000011777 magnesium Substances 0.000 claims 6
- 229910052749 magnesium Inorganic materials 0.000 claims 6
- 210000005036 nerve Anatomy 0.000 claims 6
- 230000001537 neural effect Effects 0.000 claims 6
- 210000001938 protoplast Anatomy 0.000 claims 6
- 231100000241 scar Toxicity 0.000 claims 6
- 230000001988 toxicity Effects 0.000 claims 6
- 231100000419 toxicity Toxicity 0.000 claims 6
- 108010000912 Egg Proteins Proteins 0.000 claims 5
- 102000002322 Egg Proteins Human genes 0.000 claims 5
- 241000588724 Escherichia coli Species 0.000 claims 5
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims 5
- 241000320380 Silybum Species 0.000 claims 5
- 240000006677 Vicia faba Species 0.000 claims 5
- 235000010749 Vicia faba Nutrition 0.000 claims 5
- 235000002098 Vicia faba var. major Nutrition 0.000 claims 5
- 239000003242 anti bacterial agent Substances 0.000 claims 5
- 150000001720 carbohydrates Chemical class 0.000 claims 5
- 235000014633 carbohydrates Nutrition 0.000 claims 5
- 239000002738 chelating agent Substances 0.000 claims 5
- 230000009920 chelation Effects 0.000 claims 5
- 235000012000 cholesterol Nutrition 0.000 claims 5
- 238000007667 floating Methods 0.000 claims 5
- 208000006454 hepatitis Diseases 0.000 claims 5
- 239000004615 ingredient Substances 0.000 claims 5
- 210000002751 lymph Anatomy 0.000 claims 5
- 230000001404 mediated effect Effects 0.000 claims 5
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 5
- 210000000664 rectum Anatomy 0.000 claims 5
- 230000000392 somatic effect Effects 0.000 claims 5
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 claims 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 4
- 240000002234 Allium sativum Species 0.000 claims 4
- 108091007065 BIRCs Proteins 0.000 claims 4
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims 4
- 102100031172 C-C chemokine receptor type 1 Human genes 0.000 claims 4
- 101710149814 C-C chemokine receptor type 1 Proteins 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 102000011727 Caspases Human genes 0.000 claims 4
- 108010076667 Caspases Proteins 0.000 claims 4
- 241000269333 Caudata Species 0.000 claims 4
- 241000271559 Dromaiidae Species 0.000 claims 4
- 102100034633 Homeobox expressed in ES cells 1 Human genes 0.000 claims 4
- 101001067288 Homo sapiens Homeobox expressed in ES cells 1 Proteins 0.000 claims 4
- 229920001202 Inulin Polymers 0.000 claims 4
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 4
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims 4
- 244000199866 Lactobacillus casei Species 0.000 claims 4
- 102000003792 Metallothionein Human genes 0.000 claims 4
- 108090000157 Metallothionein Proteins 0.000 claims 4
- 208000002193 Pain Diseases 0.000 claims 4
- 206010033799 Paralysis Diseases 0.000 claims 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims 4
- 108700025071 Short Stature Homeobox Proteins 0.000 claims 4
- 241000282887 Suidae Species 0.000 claims 4
- 241000282898 Sus scrofa Species 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 4
- 206010048259 Zinc deficiency Diseases 0.000 claims 4
- 230000009102 absorption Effects 0.000 claims 4
- 238000010521 absorption reaction Methods 0.000 claims 4
- 229940088710 antibiotic agent Drugs 0.000 claims 4
- 230000001580 bacterial effect Effects 0.000 claims 4
- 244000052616 bacterial pathogen Species 0.000 claims 4
- 210000000941 bile Anatomy 0.000 claims 4
- 230000008499 blood brain barrier function Effects 0.000 claims 4
- 210000001218 blood-brain barrier Anatomy 0.000 claims 4
- 229910052793 cadmium Inorganic materials 0.000 claims 4
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims 4
- 238000002655 chelation therapy Methods 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 4
- 229930002875 chlorophyll Natural products 0.000 claims 4
- 235000019804 chlorophyll Nutrition 0.000 claims 4
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims 4
- 230000001010 compromised effect Effects 0.000 claims 4
- 210000002808 connective tissue Anatomy 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- 230000008030 elimination Effects 0.000 claims 4
- 238000003379 elimination reaction Methods 0.000 claims 4
- 230000013020 embryo development Effects 0.000 claims 4
- 230000002550 fecal effect Effects 0.000 claims 4
- 238000000855 fermentation Methods 0.000 claims 4
- 230000004151 fermentation Effects 0.000 claims 4
- 239000003337 fertilizer Substances 0.000 claims 4
- 235000004611 garlic Nutrition 0.000 claims 4
- 231100000283 hepatitis Toxicity 0.000 claims 4
- 208000027866 inflammatory disease Diseases 0.000 claims 4
- 230000002757 inflammatory effect Effects 0.000 claims 4
- 238000002347 injection Methods 0.000 claims 4
- 239000007924 injection Substances 0.000 claims 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 4
- 229940029339 inulin Drugs 0.000 claims 4
- 229910052742 iron Inorganic materials 0.000 claims 4
- 229940016409 methylsulfonylmethane Drugs 0.000 claims 4
- 230000000813 microbial effect Effects 0.000 claims 4
- 238000000520 microinjection Methods 0.000 claims 4
- 230000005012 migration Effects 0.000 claims 4
- 238000013508 migration Methods 0.000 claims 4
- 210000001616 monocyte Anatomy 0.000 claims 4
- 210000003061 neural cell Anatomy 0.000 claims 4
- 210000004681 ovum Anatomy 0.000 claims 4
- 230000007170 pathology Effects 0.000 claims 4
- 230000003389 potentiating effect Effects 0.000 claims 4
- 230000002829 reductive effect Effects 0.000 claims 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims 4
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims 4
- 230000035900 sweating Effects 0.000 claims 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 3
- 241000234282 Allium Species 0.000 claims 3
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims 3
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 3
- 241001608472 Bifidobacterium longum Species 0.000 claims 3
- 244000045232 Canavalia ensiformis Species 0.000 claims 3
- 208000015879 Cerebellar disease Diseases 0.000 claims 3
- 244000018436 Coriandrum sativum Species 0.000 claims 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 3
- 206010012735 Diarrhoea Diseases 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 3
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 3
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 3
- 229930195722 L-methionine Natural products 0.000 claims 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims 3
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 claims 3
- 241000186869 Lactobacillus salivarius Species 0.000 claims 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 3
- 244000046095 Psophocarpus tetragonolobus Species 0.000 claims 3
- 241001092490 Purshia Species 0.000 claims 3
- 241000700159 Rattus Species 0.000 claims 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims 3
- 241000271567 Struthioniformes Species 0.000 claims 3
- 108010002687 Survivin Proteins 0.000 claims 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims 3
- 108010017842 Telomerase Proteins 0.000 claims 3
- 235000021307 Triticum Nutrition 0.000 claims 3
- 241000209140 Triticum Species 0.000 claims 3
- 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 claims 3
- 102100038232 Vascular endothelial growth factor C Human genes 0.000 claims 3
- 229930003268 Vitamin C Natural products 0.000 claims 3
- 229910021536 Zeolite Inorganic materials 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 3
- 230000002411 adverse Effects 0.000 claims 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims 3
- 230000006907 apoptotic process Effects 0.000 claims 3
- 210000001367 artery Anatomy 0.000 claims 3
- 238000013473 artificial intelligence Methods 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 230000007177 brain activity Effects 0.000 claims 3
- 230000006931 brain damage Effects 0.000 claims 3
- 231100000874 brain damage Toxicity 0.000 claims 3
- 208000029028 brain injury Diseases 0.000 claims 3
- 239000006227 byproduct Substances 0.000 claims 3
- 238000004113 cell culture Methods 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 230000000052 comparative effect Effects 0.000 claims 3
- 239000004062 cytokinin Substances 0.000 claims 3
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims 3
- 230000007123 defense Effects 0.000 claims 3
- 230000007850 degeneration Effects 0.000 claims 3
- 210000001787 dendrite Anatomy 0.000 claims 3
- 230000029087 digestion Effects 0.000 claims 3
- 230000001079 digestive effect Effects 0.000 claims 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims 3
- 235000014103 egg white Nutrition 0.000 claims 3
- 210000000969 egg white Anatomy 0.000 claims 3
- 230000007613 environmental effect Effects 0.000 claims 3
- 235000019197 fats Nutrition 0.000 claims 3
- 235000012055 fruits and vegetables Nutrition 0.000 claims 3
- 239000010903 husk Substances 0.000 claims 3
- 238000011534 incubation Methods 0.000 claims 3
- 230000028709 inflammatory response Effects 0.000 claims 3
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 3
- 210000003734 kidney Anatomy 0.000 claims 3
- 229940039696 lactobacillus Drugs 0.000 claims 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims 3
- 229910052750 molybdenum Inorganic materials 0.000 claims 3
- 239000011733 molybdenum Substances 0.000 claims 3
- 238000002703 mutagenesis Methods 0.000 claims 3
- 231100000350 mutagenesis Toxicity 0.000 claims 3
- 230000007935 neutral effect Effects 0.000 claims 3
- 210000000440 neutrophil Anatomy 0.000 claims 3
- 210000004940 nucleus Anatomy 0.000 claims 3
- 229920001542 oligosaccharide Polymers 0.000 claims 3
- 150000002482 oligosaccharides Chemical class 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 231100000614 poison Toxicity 0.000 claims 3
- 239000003755 preservative agent Substances 0.000 claims 3
- 235000021251 pulses Nutrition 0.000 claims 3
- 150000003254 radicals Chemical class 0.000 claims 3
- 230000037390 scarring Effects 0.000 claims 3
- 230000001568 sexual effect Effects 0.000 claims 3
- 210000001082 somatic cell Anatomy 0.000 claims 3
- ACTRVOBWPAIOHC-UHFFFAOYSA-N succimer Chemical compound OC(=O)C(S)C(S)C(O)=O ACTRVOBWPAIOHC-UHFFFAOYSA-N 0.000 claims 3
- 230000009469 supplementation Effects 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 235000013311 vegetables Nutrition 0.000 claims 3
- 210000003462 vein Anatomy 0.000 claims 3
- 235000019154 vitamin C Nutrition 0.000 claims 3
- 239000011718 vitamin C Substances 0.000 claims 3
- 239000010457 zeolite Substances 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims 2
- 229910001312 Amalgam (dentistry) Inorganic materials 0.000 claims 2
- 206010003694 Atrophy Diseases 0.000 claims 2
- 241001532704 Azolla Species 0.000 claims 2
- 229920005721 BUTONAL® Polymers 0.000 claims 2
- 241000606125 Bacteroides Species 0.000 claims 2
- 102100023995 Beta-nerve growth factor Human genes 0.000 claims 2
- 241000219495 Betulaceae Species 0.000 claims 2
- 240000007124 Brassica oleracea Species 0.000 claims 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 2
- 101150012716 CDK1 gene Proteins 0.000 claims 2
- 101100381481 Caenorhabditis elegans baz-2 gene Proteins 0.000 claims 2
- 235000010520 Canavalia ensiformis Nutrition 0.000 claims 2
- 102100026548 Caspase-8 Human genes 0.000 claims 2
- 108090000538 Caspase-8 Proteins 0.000 claims 2
- 108010059892 Cellulase Proteins 0.000 claims 2
- 241001092054 Cercocarpus Species 0.000 claims 2
- 241001243662 Chamaebatia Species 0.000 claims 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 2
- 241000227999 Coffea canephora Species 0.000 claims 2
- 241001572170 Coffea liberica var. dewevrei Species 0.000 claims 2
- 235000002187 Coffea robusta Nutrition 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims 2
- 102000003849 Cytochrome P450 Human genes 0.000 claims 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims 2
- 102000004648 Distal-less homeobox proteins Human genes 0.000 claims 2
- 108010003661 Distal-less homeobox proteins Proteins 0.000 claims 2
- 241001508399 Elaeagnus Species 0.000 claims 2
- 244000223060 Erythrina herbacea Species 0.000 claims 2
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims 2
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims 2
- 208000001640 Fibromyalgia Diseases 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims 2
- 229920001503 Glucan Polymers 0.000 claims 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 108010051696 Growth Hormone Proteins 0.000 claims 2
- 101150033506 HOX gene Proteins 0.000 claims 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 2
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 claims 2
- 102100022377 Homeobox protein DLX-2 Human genes 0.000 claims 2
- 102100022376 Homeobox protein DLX-3 Human genes 0.000 claims 2
- 102100022374 Homeobox protein DLX-4 Human genes 0.000 claims 2
- 102100035349 Homeobox protein DLX-6 Human genes 0.000 claims 2
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 claims 2
- 101000901635 Homo sapiens Homeobox protein DLX-2 Proteins 0.000 claims 2
- 101000901646 Homo sapiens Homeobox protein DLX-3 Proteins 0.000 claims 2
- 101000901614 Homo sapiens Homeobox protein DLX-4 Proteins 0.000 claims 2
- 101000804582 Homo sapiens Homeobox protein DLX-6 Proteins 0.000 claims 2
- 101100477520 Homo sapiens SHOX gene Proteins 0.000 claims 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 102000040104 IAP family Human genes 0.000 claims 2
- 108091069885 IAP family Proteins 0.000 claims 2
- 101710205425 Immediate-early protein 2 Proteins 0.000 claims 2
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 claims 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims 2
- 102000004125 Interleukin-1alpha Human genes 0.000 claims 2
- 108010082786 Interleukin-1alpha Proteins 0.000 claims 2
- 208000005615 Interstitial Cystitis Diseases 0.000 claims 2
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- 235000010671 Lathyrus sativus Nutrition 0.000 claims 2
- 240000005783 Lathyrus sativus Species 0.000 claims 2
- 235000007252 Lathyrus tuberosus Nutrition 0.000 claims 2
- 244000237786 Lathyrus tuberosus Species 0.000 claims 2
- 241000219739 Lens Species 0.000 claims 2
- 241000186781 Listeria Species 0.000 claims 2
- 241000219745 Lupinus Species 0.000 claims 2
- 240000005265 Lupinus mutabilis Species 0.000 claims 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 102000043136 MAP kinase family Human genes 0.000 claims 2
- 108091054455 MAP kinase family Proteins 0.000 claims 2
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims 2
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims 2
- 244000131099 Macrotyloma uniflorum Species 0.000 claims 2
- 102000011961 Maturation-Promoting Factor Human genes 0.000 claims 2
- 108010075942 Maturation-Promoting Factor Proteins 0.000 claims 2
- 240000004658 Medicago sativa Species 0.000 claims 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 2
- 208000008763 Mercury poisoning Diseases 0.000 claims 2
- 206010027439 Metal poisoning Diseases 0.000 claims 2
- 208000016285 Movement disease Diseases 0.000 claims 2
- 241000699670 Mus sp. Species 0.000 claims 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims 2
- 102100021126 N-formyl peptide receptor 2 Human genes 0.000 claims 2
- 101710091942 N-formyl peptide receptor 2 Proteins 0.000 claims 2
- 229910002651 NO3 Inorganic materials 0.000 claims 2
- 235000019482 Palm oil Nutrition 0.000 claims 2
- 229930182555 Penicillin Natural products 0.000 claims 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 2
- 206010057249 Phagocytosis Diseases 0.000 claims 2
- 241000219843 Pisum Species 0.000 claims 2
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims 2
- 101100372762 Rattus norvegicus Flt1 gene Proteins 0.000 claims 2
- 241000219100 Rhamnaceae Species 0.000 claims 2
- 108020001027 Ribosomal DNA Proteins 0.000 claims 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 2
- 241001508793 Shepherdia Species 0.000 claims 2
- 102000048489 Short Stature Homeobox Human genes 0.000 claims 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 102100038803 Somatotropin Human genes 0.000 claims 2
- 208000003954 Spinal Muscular Atrophies of Childhood Diseases 0.000 claims 2
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 2
- 108010012715 Superoxide dismutase Proteins 0.000 claims 2
- 102000040945 Transcription factor Human genes 0.000 claims 2
- 108091023040 Transcription factor Proteins 0.000 claims 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 claims 2
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 2
- 102000009270 Tumour necrosis factor alpha Human genes 0.000 claims 2
- 108050000101 Tumour necrosis factor alpha Proteins 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- 108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 claims 2
- 102000016663 Vascular Endothelial Growth Factor Receptor-3 Human genes 0.000 claims 2
- 241000219977 Vigna Species 0.000 claims 2
- 101710160067 Viral transcription factor IE2 Proteins 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- 208000034817 Waterborne disease Diseases 0.000 claims 2
- 108010076089 accutase Proteins 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 208000018254 acute transverse myelitis Diseases 0.000 claims 2
- 210000004504 adult stem cell Anatomy 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 239000002473 artificial blood Substances 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 230000037444 atrophy Effects 0.000 claims 2
- 230000003190 augmentative effect Effects 0.000 claims 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 208000018300 basal ganglia disease Diseases 0.000 claims 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 claims 2
- 239000003613 bile acid Substances 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 239000011111 cardboard Substances 0.000 claims 2
- 150000001746 carotenes Chemical class 0.000 claims 2
- 235000005473 carotenes Nutrition 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 208000014797 chronic intestinal pseudoobstruction Diseases 0.000 claims 2
- 230000004087 circulation Effects 0.000 claims 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000004927 clay Substances 0.000 claims 2
- 235000009508 confectionery Nutrition 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 2
- 230000036461 convulsion Effects 0.000 claims 2
- 229910052802 copper Inorganic materials 0.000 claims 2
- 239000010949 copper Substances 0.000 claims 2
- 229960003067 cystine Drugs 0.000 claims 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 2
- 231100000433 cytotoxic Toxicity 0.000 claims 2
- 230000001472 cytotoxic effect Effects 0.000 claims 2
- 235000013365 dairy product Nutrition 0.000 claims 2
- 230000002950 deficient Effects 0.000 claims 2
- 230000003210 demyelinating effect Effects 0.000 claims 2
- 239000000448 dental amalgam Substances 0.000 claims 2
- 230000000378 dietary effect Effects 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 235000019621 digestibility Nutrition 0.000 claims 2
- 210000002249 digestive system Anatomy 0.000 claims 2
- 235000013399 edible fruits Nutrition 0.000 claims 2
- 230000002500 effect on skin Effects 0.000 claims 2
- 239000003792 electrolyte Substances 0.000 claims 2
- 230000037149 energy metabolism Effects 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 239000004060 excitotoxin Substances 0.000 claims 2
- 230000007717 exclusion Effects 0.000 claims 2
- 206010016256 fatigue Diseases 0.000 claims 2
- 230000008175 fetal development Effects 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 238000011049 filling Methods 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- 230000037406 food intake Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 2
- 230000000762 glandular Effects 0.000 claims 2
- 239000011521 glass Substances 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 2
- 239000000383 hazardous chemical Substances 0.000 claims 2
- 239000002920 hazardous waste Substances 0.000 claims 2
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 2
- 235000008216 herbs Nutrition 0.000 claims 2
- 230000003284 homeostatic effect Effects 0.000 claims 2
- 102000058223 human VEGFA Human genes 0.000 claims 2
- 230000006872 improvement Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 229940059406 lactobacillus rhamnosus gg Drugs 0.000 claims 2
- 229940066544 lactobacillus sporogenes Drugs 0.000 claims 2
- 235000021374 legumes Nutrition 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 230000003859 lipid peroxidation Effects 0.000 claims 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 2
- 235000019136 lipoic acid Nutrition 0.000 claims 2
- 230000001926 lymphatic effect Effects 0.000 claims 2
- 210000004324 lymphatic system Anatomy 0.000 claims 2
- 201000004792 malaria Diseases 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 231100000783 metal toxicity Toxicity 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- 230000002438 mitochondrial effect Effects 0.000 claims 2
- 230000000394 mitotic effect Effects 0.000 claims 2
- 210000004877 mucosa Anatomy 0.000 claims 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 208000015380 nutritional deficiency disease Diseases 0.000 claims 2
- 239000002540 palm oil Substances 0.000 claims 2
- 229940049954 penicillin Drugs 0.000 claims 2
- 239000000575 pesticide Substances 0.000 claims 2
- 230000008782 phagocytosis Effects 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 235000002949 phytic acid Nutrition 0.000 claims 2
- 239000002574 poison Substances 0.000 claims 2
- 235000017924 poor diet Nutrition 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 235000021489 probiotic drink Nutrition 0.000 claims 2
- 102000003998 progesterone receptors Human genes 0.000 claims 2
- 108090000468 progesterone receptors Proteins 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 230000002797 proteolythic effect Effects 0.000 claims 2
- 208000009954 pyoderma gangrenosum Diseases 0.000 claims 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 230000009103 reabsorption Effects 0.000 claims 2
- 210000005084 renal tissue Anatomy 0.000 claims 2
- 230000002629 repopulating effect Effects 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 230000033764 rhythmic process Effects 0.000 claims 2
- 230000000630 rising effect Effects 0.000 claims 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 239000011669 selenium Substances 0.000 claims 2
- 229910052711 selenium Inorganic materials 0.000 claims 2
- 238000012163 sequencing technique Methods 0.000 claims 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 claims 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
- 150000004666 short chain fatty acids Chemical class 0.000 claims 2
- 238000004904 shortening Methods 0.000 claims 2
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 claims 2
- 210000000813 small intestine Anatomy 0.000 claims 2
- 238000009987 spinning Methods 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- 239000010902 straw Substances 0.000 claims 2
- 229960005322 streptomycin Drugs 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 125000004354 sulfur functional group Chemical group 0.000 claims 2
- 230000002459 sustained effect Effects 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- 229960003080 taurine Drugs 0.000 claims 2
- 229960002663 thioctic acid Drugs 0.000 claims 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 238000012549 training Methods 0.000 claims 2
- 230000002103 transcriptional effect Effects 0.000 claims 2
- 230000001052 transient effect Effects 0.000 claims 2
- 208000009174 transverse myelitis Diseases 0.000 claims 2
- 210000004291 uterus Anatomy 0.000 claims 2
- 229940094720 viagra Drugs 0.000 claims 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims 2
- 235000019158 vitamin B6 Nutrition 0.000 claims 2
- 239000011726 vitamin B6 Substances 0.000 claims 2
- 235000019165 vitamin E Nutrition 0.000 claims 2
- 239000011709 vitamin E Substances 0.000 claims 2
- 229940046009 vitamin E Drugs 0.000 claims 2
- 239000002023 wood Substances 0.000 claims 2
- 239000002916 wood waste Substances 0.000 claims 2
- 235000020138 yakult Nutrition 0.000 claims 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims 1
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 claims 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims 1
- CDOSHBSSFJOMGT-SNVBAGLBSA-N (S)-linalool Chemical compound CC(C)=CCC[C@](C)(O)C=C CDOSHBSSFJOMGT-SNVBAGLBSA-N 0.000 claims 1
- VLTXBOGHSBHSAC-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6-undecafluoro-6-[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]cyclohexane Chemical compound FC(F)(F)C(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F VLTXBOGHSBHSAC-UHFFFAOYSA-N 0.000 claims 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims 1
- 102000004899 14-3-3 Proteins Human genes 0.000 claims 1
- 101710112812 14-3-3 protein Proteins 0.000 claims 1
- UPLPHRJJTCUQAY-WIRWPRASSA-N 2,3-thioepoxy madol Chemical compound C([C@@H]1CC2)[C@@H]3S[C@@H]3C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C)(O)[C@@]2(C)CC1 UPLPHRJJTCUQAY-WIRWPRASSA-N 0.000 claims 1
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 claims 1
- ULUOXCRNSRVJPE-MJRHPTFMSA-N 2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]propanoyl]amino]propanoyl]amino]acetic acid Chemical compound C([C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(O)=O)C1=CN=CN1 ULUOXCRNSRVJPE-MJRHPTFMSA-N 0.000 claims 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 108010011619 6-Phytase Proteins 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 241000186042 Actinomyces bovis Species 0.000 claims 1
- 229930024421 Adenine Natural products 0.000 claims 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 206010027654 Allergic conditions Diseases 0.000 claims 1
- 241000270728 Alligator Species 0.000 claims 1
- 241001541997 Allionia Species 0.000 claims 1
- 241000792874 Allocasuarina Species 0.000 claims 1
- 241000219496 Alnus Species 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 claims 1
- 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 claims 1
- 101710106364 Apoptosis inhibitor 1 Proteins 0.000 claims 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 1
- 241000512259 Ascophyllum nodosum Species 0.000 claims 1
- 244000003416 Asparagus officinalis Species 0.000 claims 1
- 235000005340 Asparagus officinalis Nutrition 0.000 claims 1
- 206010003591 Ataxia Diseases 0.000 claims 1
- 206010003594 Ataxia telangiectasia Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 229930192334 Auxin Natural products 0.000 claims 1
- 244000075850 Avena orientalis Species 0.000 claims 1
- 235000007319 Avena orientalis Nutrition 0.000 claims 1
- 241000589154 Azotobacter group Species 0.000 claims 1
- 102100027955 BAG family molecular chaperone regulator 4 Human genes 0.000 claims 1
- 101710089799 BAG family molecular chaperone regulator 4 Proteins 0.000 claims 1
- 241000206761 Bacillariophyta Species 0.000 claims 1
- 108010062877 Bacteriocins Proteins 0.000 claims 1
- 208000023328 Basedow disease Diseases 0.000 claims 1
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 claims 1
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 claims 1
- 235000021537 Beetroot Nutrition 0.000 claims 1
- 235000018185 Betula X alpestris Nutrition 0.000 claims 1
- 235000018212 Betula X uliginosa Nutrition 0.000 claims 1
- 241001474374 Blennius Species 0.000 claims 1
- 208000035049 Blood-Borne Infections Diseases 0.000 claims 1
- 241000219198 Brassica Species 0.000 claims 1
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 240000002791 Brassica napus Species 0.000 claims 1
- 235000011293 Brassica napus Nutrition 0.000 claims 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 206010006326 Breath odour Diseases 0.000 claims 1
- 241000193417 Brevibacillus laterosporus Species 0.000 claims 1
- 241000273930 Brevoortia tyrannus Species 0.000 claims 1
- 208000011691 Burkitt lymphomas Diseases 0.000 claims 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 claims 1
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims 1
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 1
- 102100036305 C-C chemokine receptor type 8 Human genes 0.000 claims 1
- 101710082513 C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 241000220442 Cajanus Species 0.000 claims 1
- 241000220450 Cajanus cajan Species 0.000 claims 1
- 235000010773 Cajanus indicus Nutrition 0.000 claims 1
- 244000105627 Cajanus indicus Species 0.000 claims 1
- 102000016838 Calbindin 1 Human genes 0.000 claims 1
- 229910021532 Calcite Inorganic materials 0.000 claims 1
- 241000220451 Canavalia Species 0.000 claims 1
- 235000010518 Canavalia gladiata Nutrition 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 235000002566 Capsicum Nutrition 0.000 claims 1
- 101710086403 Carbonic anhydrase-related protein Proteins 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 108090000397 Caspase 3 Proteins 0.000 claims 1
- 108090000567 Caspase 7 Proteins 0.000 claims 1
- 102100029855 Caspase-3 Human genes 0.000 claims 1
- 102100038902 Caspase-7 Human genes 0.000 claims 1
- 102100026550 Caspase-9 Human genes 0.000 claims 1
- 108090000566 Caspase-9 Proteins 0.000 claims 1
- 241000219501 Casuarina Species 0.000 claims 1
- 241000219500 Casuarinaceae Species 0.000 claims 1
- 241001083940 Ceanothus Species 0.000 claims 1
- 235000014342 Ceanothus Nutrition 0.000 claims 1
- 108010084185 Cellulases Proteins 0.000 claims 1
- 102000005575 Cellulases Human genes 0.000 claims 1
- 235000009006 Cercocarpus ledifolius Nutrition 0.000 claims 1
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 235000007091 Chlorella pyrenoidosa Nutrition 0.000 claims 1
- 244000249214 Chlorella pyrenoidosa Species 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 241000195628 Chlorophyta Species 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 206010008748 Chorea Diseases 0.000 claims 1
- 108091060290 Chromatid Proteins 0.000 claims 1
- 206010008909 Chronic Hepatitis Diseases 0.000 claims 1
- 235000010521 Cicer Nutrition 0.000 claims 1
- 241000220455 Cicer Species 0.000 claims 1
- 235000010523 Cicer arietinum Nutrition 0.000 claims 1
- 244000045195 Cicer arietinum Species 0.000 claims 1
- 235000007542 Cichorium intybus Nutrition 0.000 claims 1
- 244000298479 Cichorium intybus Species 0.000 claims 1
- 241000132536 Cirsium Species 0.000 claims 1
- 102100038446 Claudin-5 Human genes 0.000 claims 1
- 108090000582 Claudin-5 Proteins 0.000 claims 1
- 241000193163 Clostridioides difficile Species 0.000 claims 1
- 208000006561 Cluster Headache Diseases 0.000 claims 1
- 241001572165 Coffea benghalensis Species 0.000 claims 1
- 241001379985 Coffea bonnieri Species 0.000 claims 1
- 241000228000 Coffea congensis Species 0.000 claims 1
- 241000176981 Coffea gallienii Species 0.000 claims 1
- 241000228031 Coffea liberica Species 0.000 claims 1
- 241000176996 Coffea mogeneti Species 0.000 claims 1
- 241000228050 Coffea stenophylla Species 0.000 claims 1
- 241000723375 Colchicum Species 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 241000219046 Colletia Species 0.000 claims 1
- 235000006481 Colocasia esculenta Nutrition 0.000 claims 1
- 244000205754 Colocasia esculenta Species 0.000 claims 1
- 241001115510 Comptonia Species 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 claims 1
- 241000218170 Coriaria Species 0.000 claims 1
- 241000218168 Coriariaceae Species 0.000 claims 1
- 235000004885 Cowania mexicana Nutrition 0.000 claims 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 claims 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 244000304337 Cuminum cyminum Species 0.000 claims 1
- 235000007129 Cuminum cyminum Nutrition 0.000 claims 1
- 241000219748 Cyamopsis Species 0.000 claims 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 1
- 241000592295 Cycadophyta Species 0.000 claims 1
- 101710093674 Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 claims 1
- 102000016736 Cyclin Human genes 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- 241000252233 Cyprinus carpio Species 0.000 claims 1
- 102100030497 Cytochrome c Human genes 0.000 claims 1
- 108010075031 Cytochromes c Proteins 0.000 claims 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 claims 1
- 230000005778 DNA damage Effects 0.000 claims 1
- 231100000277 DNA damage Toxicity 0.000 claims 1
- 101100540419 Danio rerio kdrl gene Proteins 0.000 claims 1
- 241001117810 Datisca Species 0.000 claims 1
- 241001117813 Datiscaceae Species 0.000 claims 1
- 102000010170 Death domains Human genes 0.000 claims 1
- 108050001718 Death domains Proteins 0.000 claims 1
- 206010067889 Dementia with Lewy bodies Diseases 0.000 claims 1
- 208000001490 Dengue Diseases 0.000 claims 1
- 206010012310 Dengue fever Diseases 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 claims 1
- 241000229161 Discaria Species 0.000 claims 1
- 102000015554 Dopamine receptor Human genes 0.000 claims 1
- 108050004812 Dopamine receptor Proteins 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 101100044298 Drosophila melanogaster fand gene Proteins 0.000 claims 1
- 241000229249 Dryas <angiosperm> Species 0.000 claims 1
- 208000027244 Dysbiosis Diseases 0.000 claims 1
- 101710175001 E1B protein, small T-antigen Proteins 0.000 claims 1
- 102100037024 E3 ubiquitin-protein ligase XIAP Human genes 0.000 claims 1
- 241001117772 Elaeagnaceae Species 0.000 claims 1
- 235000017643 Elaeagnus angustifolia Nutrition 0.000 claims 1
- 235000004597 Elaeagnus commutata Nutrition 0.000 claims 1
- 244000016119 Elaeagnus latifolia Species 0.000 claims 1
- 235000001456 Elaeagnus latifolia Nutrition 0.000 claims 1
- 235000007630 Elaeagnus umbellata var parvifolia Nutrition 0.000 claims 1
- 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 claims 1
- 102000006402 Endocrine-Gland-Derived Vascular Endothelial Growth Factor Human genes 0.000 claims 1
- 108010044063 Endocrine-Gland-Derived Vascular Endothelial Growth Factor Proteins 0.000 claims 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 claims 1
- 241000194031 Enterococcus faecium Species 0.000 claims 1
- 206010014896 Enterocolitis haemorrhagic Diseases 0.000 claims 1
- 208000000237 Environmental Illness Diseases 0.000 claims 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 102400001368 Epidermal growth factor Human genes 0.000 claims 1
- 101800003838 Epidermal growth factor Proteins 0.000 claims 1
- 235000005280 Erythrina herbacea Nutrition 0.000 claims 1
- 108700039887 Essential Genes Proteins 0.000 claims 1
- 102000007594 Estrogen Receptor alpha Human genes 0.000 claims 1
- 108010007005 Estrogen Receptor alpha Proteins 0.000 claims 1
- 102000000509 Estrogen Receptor beta Human genes 0.000 claims 1
- 108010041356 Estrogen Receptor beta Proteins 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 101150064015 FAS gene Proteins 0.000 claims 1
- 241000220485 Fabaceae Species 0.000 claims 1
- 241000510678 Falcaria vulgaris Species 0.000 claims 1
- 208000021663 Female sexual arousal disease Diseases 0.000 claims 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 102100028072 Fibroblast growth factor 4 Human genes 0.000 claims 1
- 102100037362 Fibronectin Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 241000187809 Frankia Species 0.000 claims 1
- 208000024412 Friedreich ataxia Diseases 0.000 claims 1
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 239000005792 Geraniol Substances 0.000 claims 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims 1
- 241001315191 Gladiata Species 0.000 claims 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 102000006771 Gonadotropins Human genes 0.000 claims 1
- 108010086677 Gonadotropins Proteins 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 1
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 1
- 241001107136 Gunnera Species 0.000 claims 1
- 241000792872 Gymnostoma Species 0.000 claims 1
- 102000005623 HSP27 Heat-Shock Proteins Human genes 0.000 claims 1
- 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 claims 1
- 108010027814 HSP72 Heat-Shock Proteins Proteins 0.000 claims 1
- 206010018910 Haemolysis Diseases 0.000 claims 1
- 206010061192 Haemorrhagic fever Diseases 0.000 claims 1
- 240000008669 Hedera helix Species 0.000 claims 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 claims 1
- 240000008892 Helianthus tuberosus Species 0.000 claims 1
- 241000590002 Helicobacter pylori Species 0.000 claims 1
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 241000229143 Hippophae Species 0.000 claims 1
- 235000003935 Hippophae Nutrition 0.000 claims 1
- 240000000950 Hippophae rhamnoides Species 0.000 claims 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims 1
- 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 claims 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 1
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 1
- 101001060274 Homo sapiens Fibroblast growth factor 4 Proteins 0.000 claims 1
- 101000585555 Homo sapiens PCNA-associated factor Proteins 0.000 claims 1
- 101000742579 Homo sapiens Vascular endothelial growth factor B Proteins 0.000 claims 1
- 101000742599 Homo sapiens Vascular endothelial growth factor D Proteins 0.000 claims 1
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 235000007340 Hordeum vulgare Nutrition 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 1
- 241000257303 Hymenoptera Species 0.000 claims 1
- 206010020649 Hyperkeratosis Diseases 0.000 claims 1
- 208000000269 Hyperkinesis Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- 102100023915 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 108010002386 Interleukin-3 Proteins 0.000 claims 1
- 102000004889 Interleukin-6 Human genes 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 101150088608 Kdr gene Proteins 0.000 claims 1
- 241000049594 Kentrothamnus Species 0.000 claims 1
- 102100020880 Kit ligand Human genes 0.000 claims 1
- 208000006264 Korsakoff syndrome Diseases 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 239000004201 L-cysteine Substances 0.000 claims 1
- 235000013878 L-cysteine Nutrition 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 1
- VVNCNSJFMMFHPL-GSVOUGTGSA-N L-penicillamine Chemical compound CC(C)(S)[C@H](N)C(O)=O VVNCNSJFMMFHPL-GSVOUGTGSA-N 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 238000008214 LDL Cholesterol Methods 0.000 claims 1
- 108010084772 LIM Domain Proteins Proteins 0.000 claims 1
- 102000005633 LIM Domain Proteins Human genes 0.000 claims 1
- 108010059881 Lactase Proteins 0.000 claims 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims 1
- 235000013958 Lactobacillus casei Nutrition 0.000 claims 1
- 241000186840 Lactobacillus fermentum Species 0.000 claims 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 201000010538 Lactose Intolerance Diseases 0.000 claims 1
- 241000282838 Lama Species 0.000 claims 1
- 235000019687 Lamb Nutrition 0.000 claims 1
- 201000008197 Laryngitis Diseases 0.000 claims 1
- 241000219729 Lathyrus Species 0.000 claims 1
- 206010024264 Lethargy Diseases 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 208000009829 Lewy Body Disease Diseases 0.000 claims 1
- 241000894731 Lobaria Species 0.000 claims 1
- 235000008755 Lupinus mutabilis Nutrition 0.000 claims 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 241000219816 Macrotyloma Species 0.000 claims 1
- 235000012549 Macrotyloma uniflorum Nutrition 0.000 claims 1
- 208000002720 Malnutrition Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims 1
- 108010052285 Membrane Proteins Proteins 0.000 claims 1
- 235000014435 Mentha Nutrition 0.000 claims 1
- 241001072983 Mentha Species 0.000 claims 1
- 206010027476 Metastases Diseases 0.000 claims 1
- 241000191938 Micrococcus luteus Species 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010061291 Mineral deficiency Diseases 0.000 claims 1
- 241000237852 Mollusca Species 0.000 claims 1
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 claims 1
- 241000122904 Mucuna Species 0.000 claims 1
- 244000111261 Mucuna pruriens Species 0.000 claims 1
- 235000008540 Mucuna pruriens var utilis Nutrition 0.000 claims 1
- 241001534756 Mungos Species 0.000 claims 1
- 240000005561 Musa balbisiana Species 0.000 claims 1
- 241000219433 Myrica Species 0.000 claims 1
- 241001115514 Myricaceae Species 0.000 claims 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 claims 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims 1
- 241000588645 Neisseria sicca Species 0.000 claims 1
- 206010029113 Neovascularisation Diseases 0.000 claims 1
- 101710138657 Neurotoxin Proteins 0.000 claims 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 1
- 241000192656 Nostoc Species 0.000 claims 1
- 108010027206 Nucleopolyhedrovirus inhibitor of apoptosis Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 206010031009 Oral pain Diseases 0.000 claims 1
- 206010068319 Oropharyngeal pain Diseases 0.000 claims 1
- 102100029879 PCNA-associated factor Human genes 0.000 claims 1
- 101150062285 PGF gene Proteins 0.000 claims 1
- 240000004371 Panax ginseng Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 241000588912 Pantoea agglomerans Species 0.000 claims 1
- 235000008753 Papaver somniferum Nutrition 0.000 claims 1
- 241000193157 Paraclostridium bifermentans Species 0.000 claims 1
- 239000006002 Pepper Substances 0.000 claims 1
- 208000008469 Peptic Ulcer Diseases 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 claims 1
- 108091005804 Peptidases Proteins 0.000 claims 1
- 241000192033 Peptostreptococcus sp. Species 0.000 claims 1
- 201000007100 Pharyngitis Diseases 0.000 claims 1
- 241000219833 Phaseolus Species 0.000 claims 1
- 240000001956 Phaseolus acutifolius Species 0.000 claims 1
- 235000008527 Phaseolus acutifolius var tenuifolius Nutrition 0.000 claims 1
- 235000006089 Phaseolus angularis Nutrition 0.000 claims 1
- 235000010632 Phaseolus coccineus Nutrition 0.000 claims 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 claims 1
- 244000042209 Phaseolus multiflorus Species 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims 1
- 240000004760 Pimpinella anisum Species 0.000 claims 1
- 235000016761 Piper aduncum Nutrition 0.000 claims 1
- 235000017804 Piper guineense Nutrition 0.000 claims 1
- 240000003889 Piper guineense Species 0.000 claims 1
- 235000008184 Piper nigrum Nutrition 0.000 claims 1
- 102100035194 Placenta growth factor Human genes 0.000 claims 1
- 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 102000002273 Polycomb Repressive Complex 1 Human genes 0.000 claims 1
- 108010000598 Polycomb Repressive Complex 1 Proteins 0.000 claims 1
- 108010022429 Polycomb-Group Proteins Proteins 0.000 claims 1
- 241000288906 Primates Species 0.000 claims 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 102000001253 Protein Kinase Human genes 0.000 claims 1
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 claims 1
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 claims 1
- 108010016131 Proto-Oncogene Proteins c-jun Proteins 0.000 claims 1
- 102000000427 Proto-Oncogene Proteins c-jun Human genes 0.000 claims 1
- 208000032225 Proximal spinal muscular atrophy type 1 Diseases 0.000 claims 1
- 208000033526 Proximal spinal muscular atrophy type 3 Diseases 0.000 claims 1
- 241000219845 Psophocarpus Species 0.000 claims 1
- 235000014465 Psophocarpus palustris Nutrition 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 claims 1
- 208000005587 Refsum Disease Diseases 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 241000049527 Retanilla Species 0.000 claims 1
- 241000220317 Rosa Species 0.000 claims 1
- 235000004789 Rosa xanthina Nutrition 0.000 claims 1
- 241000220222 Rosaceae Species 0.000 claims 1
- 240000007651 Rubus glaucus Species 0.000 claims 1
- 101100465401 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SCL1 gene Proteins 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 1
- 241001037421 Sarcina sp. Species 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 244000082988 Secale cereale Species 0.000 claims 1
- 235000007238 Secale cereale Nutrition 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 241000607694 Serratia odorifera Species 0.000 claims 1
- 241000533293 Sesbania emerus Species 0.000 claims 1
- 235000006449 Shepherdia argentea Nutrition 0.000 claims 1
- 108010017898 Shiga Toxins Proteins 0.000 claims 1
- 241000607762 Shigella flexneri Species 0.000 claims 1
- 244000272459 Silybum marianum Species 0.000 claims 1
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 244000061457 Solanum nigrum Species 0.000 claims 1
- 235000000342 Solanum rostratum Nutrition 0.000 claims 1
- 102000005157 Somatostatin Human genes 0.000 claims 1
- 108010056088 Somatostatin Proteins 0.000 claims 1
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims 1
- 208000011641 Spinocerebellar disease Diseases 0.000 claims 1
- 108010039445 Stem Cell Factor Proteins 0.000 claims 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 claims 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 102100037219 Syntenin-1 Human genes 0.000 claims 1
- 108010083130 Syntenins Proteins 0.000 claims 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 claims 1
- 206010043269 Tension headache Diseases 0.000 claims 1
- 208000008548 Tension-Type Headache Diseases 0.000 claims 1
- 241000492514 Tetragonolobus Species 0.000 claims 1
- 240000002657 Thymus vulgaris Species 0.000 claims 1
- 235000007303 Thymus vulgaris Nutrition 0.000 claims 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 206010044314 Tracheobronchitis Diseases 0.000 claims 1
- 108010009583 Transforming Growth Factors Proteins 0.000 claims 1
- 102000009618 Transforming Growth Factors Human genes 0.000 claims 1
- 102100025946 Transforming growth factor beta activator LRRC32 Human genes 0.000 claims 1
- 101710169732 Transforming growth factor beta activator LRRC32 Proteins 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 241000229167 Trevoa Species 0.000 claims 1
- 241000223261 Trichoderma viride Species 0.000 claims 1
- 206010044688 Trisomy 21 Diseases 0.000 claims 1
- 235000007264 Triticum durum Nutrition 0.000 claims 1
- 240000002805 Triticum turgidum Species 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 102100033019 Tyrosine-protein phosphatase non-receptor type 11 Human genes 0.000 claims 1
- 101710116241 Tyrosine-protein phosphatase non-receptor type 11 Proteins 0.000 claims 1
- 101150095130 URAD gene Proteins 0.000 claims 1
- 102100024205 Ubiquitin carboxyl-terminal hydrolase MINDY-3 Human genes 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 235000009108 Urtica dioica Nutrition 0.000 claims 1
- 241000218215 Urticaceae Species 0.000 claims 1
- 206010046914 Vaginal infection Diseases 0.000 claims 1
- 201000008100 Vaginitis Diseases 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 235000009499 Vanilla fragrans Nutrition 0.000 claims 1
- 244000263375 Vanilla tahitensis Species 0.000 claims 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims 1
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 1
- 208000001407 Vascular Headaches Diseases 0.000 claims 1
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims 1
- 102100038217 Vascular endothelial growth factor B Human genes 0.000 claims 1
- 102100038234 Vascular endothelial growth factor D Human genes 0.000 claims 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims 1
- 241000219873 Vicia Species 0.000 claims 1
- 235000010725 Vigna aconitifolia Nutrition 0.000 claims 1
- 244000042325 Vigna aconitifolia Species 0.000 claims 1
- 240000007098 Vigna angularis Species 0.000 claims 1
- 235000010711 Vigna angularis Nutrition 0.000 claims 1
- 244000042295 Vigna mungo Species 0.000 claims 1
- 235000010716 Vigna mungo Nutrition 0.000 claims 1
- 240000004922 Vigna radiata Species 0.000 claims 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims 1
- 235000010726 Vigna sinensis Nutrition 0.000 claims 1
- 235000011453 Vigna umbellata Nutrition 0.000 claims 1
- 244000042314 Vigna unguiculata Species 0.000 claims 1
- 244000240068 Vigna unguiculata ssp sesquipedalis Species 0.000 claims 1
- 235000005755 Vigna unguiculata ssp. sesquipedalis Nutrition 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 1
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 241000272195 Vultur Species 0.000 claims 1
- 201000008485 Wernicke-Korsakoff syndrome Diseases 0.000 claims 1
- 108700031544 X-Linked Inhibitor of Apoptosis Proteins 0.000 claims 1
- 229960004373 acetylcholine Drugs 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000006978 adaptation Effects 0.000 claims 1
- 229960000643 adenine Drugs 0.000 claims 1
- 208000030597 adult Refsum disease Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 239000013572 airborne allergen Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 238000012867 alanine scanning Methods 0.000 claims 1
- 230000000172 allergic effect Effects 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 210000002226 anterior horn cell Anatomy 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 238000009360 aquaculture Methods 0.000 claims 1
- 244000144974 aquaculture Species 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 239000010426 asphalt Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 230000002567 autonomic effect Effects 0.000 claims 1
- 239000002363 auxin Substances 0.000 claims 1
- 206010064097 avian influenza Diseases 0.000 claims 1
- 108010042854 bacteria histone-like protein HU Proteins 0.000 claims 1
- 235000021015 bananas Nutrition 0.000 claims 1
- 210000004227 basal ganglia Anatomy 0.000 claims 1
- 102000055102 bcl-2-Associated X Human genes 0.000 claims 1
- 108700000707 bcl-2-Associated X Proteins 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 108010005774 beta-Galactosidase Proteins 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims 1
- 230000010234 biliary secretion Effects 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 1
- 235000005774 blackeyed pea Nutrition 0.000 claims 1
- 210000004952 blastocoel Anatomy 0.000 claims 1
- 208000024330 bloating Diseases 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 claims 1
- 230000023555 blood coagulation Effects 0.000 claims 1
- 230000036765 blood level Effects 0.000 claims 1
- 230000036770 blood supply Effects 0.000 claims 1
- 230000004641 brain development Effects 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 239000011449 brick Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000004566 building material Substances 0.000 claims 1
- 229960002092 busulfan Drugs 0.000 claims 1
- 239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 claims 1
- 235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-L calcium;disodium;2-[2-[bis(carboxylatomethyl)azaniumyl]ethyl-(carboxylatomethyl)azaniumyl]acetate Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-L 0.000 claims 1
- 208000001969 capillary hemangioma Diseases 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 238000004177 carbon cycle Methods 0.000 claims 1
- 239000011852 carbon nanoparticle Substances 0.000 claims 1
- 239000002041 carbon nanotube Substances 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 238000012219 cassette mutagenesis Methods 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 230000022131 cell cycle Effects 0.000 claims 1
- 230000011712 cell development Effects 0.000 claims 1
- 230000003915 cell function Effects 0.000 claims 1
- 210000000170 cell membrane Anatomy 0.000 claims 1
- 239000006285 cell suspension Substances 0.000 claims 1
- 229940106157 cellulase Drugs 0.000 claims 1
- 210000003793 centrosome Anatomy 0.000 claims 1
- 239000004464 cereal grain Substances 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- 210000001638 cerebellum Anatomy 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 210000004756 chromatid Anatomy 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 229940117229 cialis Drugs 0.000 claims 1
- 230000001886 ciliary effect Effects 0.000 claims 1
- 235000000484 citronellol Nutrition 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 238000009535 clinical urine test Methods 0.000 claims 1
- 239000003245 coal Substances 0.000 claims 1
- 229940110456 cocoa butter Drugs 0.000 claims 1
- 235000019868 cocoa butter Nutrition 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 229920002770 condensed tannin Polymers 0.000 claims 1
- 230000001268 conjugating effect Effects 0.000 claims 1
- 230000008473 connective tissue growth Effects 0.000 claims 1
- 238000010411 cooking Methods 0.000 claims 1
- 239000001359 coriandrum sativum l. oleoresin Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 230000002594 corticospinal effect Effects 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 claims 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 108091007930 cytoplasmic receptors Proteins 0.000 claims 1
- 229940104302 cytosine Drugs 0.000 claims 1
- 230000034994 death Effects 0.000 claims 1
- 231100000517 death Toxicity 0.000 claims 1
- 230000004040 defense response to microbe Effects 0.000 claims 1
- 230000018044 dehydration Effects 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 238000002716 delivery method Methods 0.000 claims 1
- 208000017004 dementia pugilistica Diseases 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 208000025729 dengue disease Diseases 0.000 claims 1
- 230000000779 depleting effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000009568 diazotrophic growth Effects 0.000 claims 1
- 235000021004 dietary regimen Nutrition 0.000 claims 1
- 102000038379 digestive enzymes Human genes 0.000 claims 1
- 108091007734 digestive enzymes Proteins 0.000 claims 1
- 108700003601 dimethylglycine Proteins 0.000 claims 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 claims 1
- 230000009429 distress Effects 0.000 claims 1
- 238000009826 distribution Methods 0.000 claims 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 1
- 238000005553 drilling Methods 0.000 claims 1
- 238000002651 drug therapy Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 208000000718 duodenal ulcer Diseases 0.000 claims 1
- 230000007140 dysbiosis Effects 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 206010013932 dyslexia Diseases 0.000 claims 1
- 210000005069 ears Anatomy 0.000 claims 1
- 210000002969 egg yolk Anatomy 0.000 claims 1
- 235000013345 egg yolk Nutrition 0.000 claims 1
- 230000002996 emotional effect Effects 0.000 claims 1
- 210000002889 endothelial cell Anatomy 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 210000003038 endothelium Anatomy 0.000 claims 1
- 239000002158 endotoxin Substances 0.000 claims 1
- 230000007515 enzymatic degradation Effects 0.000 claims 1
- 229940116977 epidermal growth factor Drugs 0.000 claims 1
- 230000007608 epigenetic mechanism Effects 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 230000008472 epithelial growth Effects 0.000 claims 1
- 230000008029 eradication Effects 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 238000002474 experimental method Methods 0.000 claims 1
- 210000003722 extracellular fluid Anatomy 0.000 claims 1
- 210000001723 extracellular space Anatomy 0.000 claims 1
- 230000004438 eyesight Effects 0.000 claims 1
- 239000002979 fabric softener Substances 0.000 claims 1
- 239000006052 feed supplement Substances 0.000 claims 1
- 235000021107 fermented food Nutrition 0.000 claims 1
- 239000002871 fertility agent Substances 0.000 claims 1
- 230000004720 fertilization Effects 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000010579 first pass effect Methods 0.000 claims 1
- 206010016766 flatulence Diseases 0.000 claims 1
- 229930003935 flavonoid Natural products 0.000 claims 1
- 150000002215 flavonoids Chemical class 0.000 claims 1
- 235000017173 flavonoids Nutrition 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 239000011888 foil Substances 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 229960000304 folic acid Drugs 0.000 claims 1
- 239000013568 food allergen Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000002509 fulvic acid Substances 0.000 claims 1
- 229940095100 fulvic acid Drugs 0.000 claims 1
- 239000001530 fumaric acid Substances 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000001156 gastric mucosa Anatomy 0.000 claims 1
- 244000000036 gastrointestinal pathogen Species 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 229940113224 gelatin pill Drugs 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 102000034356 gene-regulatory proteins Human genes 0.000 claims 1
- 108091006104 gene-regulatory proteins Proteins 0.000 claims 1
- 238000010353 genetic engineering Methods 0.000 claims 1
- 238000012268 genome sequencing Methods 0.000 claims 1
- 229940113087 geraniol Drugs 0.000 claims 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 210000001703 glandular epithelial cell Anatomy 0.000 claims 1
- 230000002518 glial effect Effects 0.000 claims 1
- 238000003881 globally optimized alternating phase rectangular pulse Methods 0.000 claims 1
- 229960002849 glucosamine sulfate Drugs 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 1
- 239000002622 gonadotropin Substances 0.000 claims 1
- 230000036449 good health Effects 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 235000020072 grain neutral spirit Nutrition 0.000 claims 1
- 235000021384 green leafy vegetables Nutrition 0.000 claims 1
- 208000037824 growth disorder Diseases 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000012447 hatching Effects 0.000 claims 1
- 230000007407 health benefit Effects 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 108010002430 hemicellulase Proteins 0.000 claims 1
- 230000008588 hemolysis Effects 0.000 claims 1
- 230000011132 hemopoiesis Effects 0.000 claims 1
- 208000014617 hemorrhoid Diseases 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 230000010224 hepatic metabolism Effects 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 235000003642 hunger Nutrition 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 229960002591 hydroxyproline Drugs 0.000 claims 1
- 230000003483 hypokinetic effect Effects 0.000 claims 1
- 230000036543 hypotension Effects 0.000 claims 1
- 230000036737 immune function Effects 0.000 claims 1
- 230000008105 immune reaction Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 201000001881 impotence Diseases 0.000 claims 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims 1
- 230000006882 induction of apoptosis Effects 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 238000009309 intensive farming Methods 0.000 claims 1
- 229940100601 interleukin-6 Drugs 0.000 claims 1
- 230000007413 intestinal health Effects 0.000 claims 1
- 210000005061 intracellular organelle Anatomy 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 230000000622 irritating effect Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 201000004815 juvenile spinal muscular atrophy Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 230000002147 killing effect Effects 0.000 claims 1
- 210000002415 kinetochore Anatomy 0.000 claims 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims 1
- 229940017800 lactobacillus casei Drugs 0.000 claims 1
- 229940072205 lactobacillus plantarum Drugs 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 230000002045 lasting effect Effects 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- 206010024378 leukocytosis Diseases 0.000 claims 1
- 210000004558 lewy body Anatomy 0.000 claims 1
- 230000000670 limiting effect Effects 0.000 claims 1
- 238000007443 liposuction Methods 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 230000003908 liver function Effects 0.000 claims 1
- 210000005228 liver tissue Anatomy 0.000 claims 1
- 230000008376 long-term health Effects 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 231100000053 low toxicity Toxicity 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 230000000527 lymphocytic effect Effects 0.000 claims 1
- 230000005291 magnetic effect Effects 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 230000036210 malignancy Effects 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 230000001071 malnutrition Effects 0.000 claims 1
- 235000000824 malnutrition Nutrition 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 229910052748 manganese Inorganic materials 0.000 claims 1
- 238000013507 mapping Methods 0.000 claims 1
- 229960003987 melatonin Drugs 0.000 claims 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 230000003923 mental ability Effects 0.000 claims 1
- 201000003102 mental depression Diseases 0.000 claims 1
- 150000002730 mercury Chemical class 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 230000007102 metabolic function Effects 0.000 claims 1
- 230000037353 metabolic pathway Effects 0.000 claims 1
- 150000002736 metal compounds Chemical class 0.000 claims 1
- 230000031864 metaphase Effects 0.000 claims 1
- 210000001724 microfibril Anatomy 0.000 claims 1
- 244000005706 microflora Species 0.000 claims 1
- 239000012982 microporous membrane Substances 0.000 claims 1
- 230000027939 micturition Effects 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 150000007522 mineralic acids Chemical class 0.000 claims 1
- 238000005065 mining Methods 0.000 claims 1
- 235000014569 mints Nutrition 0.000 claims 1
- 210000000479 mitotic spindle apparatus Anatomy 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 201000000585 muscular atrophy Diseases 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- 201000005962 mycosis fungoides Diseases 0.000 claims 1
- 229950006780 n-acetylglucosamine Drugs 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 claims 1
- 239000002581 neurotoxin Substances 0.000 claims 1
- 231100000618 neurotoxin Toxicity 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- 150000002823 nitrates Chemical class 0.000 claims 1
- 150000002826 nitrites Chemical class 0.000 claims 1
- 238000004172 nitrogen cycle Methods 0.000 claims 1
- 229960002748 norepinephrine Drugs 0.000 claims 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 claims 1
- 210000000633 nuclear envelope Anatomy 0.000 claims 1
- 230000000050 nutritive effect Effects 0.000 claims 1
- 229940038580 oat bran Drugs 0.000 claims 1
- 239000004465 oilseed meal Substances 0.000 claims 1
- GTVPOLSIJWJJNY-UHFFFAOYSA-N olomoucine Chemical compound N1=C(NCCO)N=C2N(C)C=NC2=C1NCC1=CC=CC=C1 GTVPOLSIJWJJNY-UHFFFAOYSA-N 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 230000004792 oxidative damage Effects 0.000 claims 1
- 229940124583 pain medication Drugs 0.000 claims 1
- 208000021090 palsy Diseases 0.000 claims 1
- 239000011087 paperboard Substances 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000006072 paste Substances 0.000 claims 1
- 229920001277 pectin Polymers 0.000 claims 1
- 239000001814 pectin Substances 0.000 claims 1
- 235000010987 pectin Nutrition 0.000 claims 1
- 230000001175 peptic effect Effects 0.000 claims 1
- 208000011906 peptic ulcer disease Diseases 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 claims 1
- 210000001986 peyer's patch Anatomy 0.000 claims 1
- 210000001539 phagocyte Anatomy 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 239000003016 pheromone Substances 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 229940085127 phytase Drugs 0.000 claims 1
- 239000000467 phytic acid Substances 0.000 claims 1
- 229940068041 phytic acid Drugs 0.000 claims 1
- 229930195732 phytohormone Natural products 0.000 claims 1
- 229940023488 pill Drugs 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 210000004180 plasmocyte Anatomy 0.000 claims 1
- 238000009428 plumbing Methods 0.000 claims 1
- 230000007096 poisonous effect Effects 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 210000004258 portal system Anatomy 0.000 claims 1
- 210000003240 portal vein Anatomy 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 230000003244 pro-oxidative effect Effects 0.000 claims 1
- 235000008428 probiotic yoghurt drink Nutrition 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 108060006633 protein kinase Proteins 0.000 claims 1
- 150000003212 purines Chemical class 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- 229960001327 pyridoxal phosphate Drugs 0.000 claims 1
- 238000003908 quality control method Methods 0.000 claims 1
- 235000021013 raspberries Nutrition 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 238000009877 rendering Methods 0.000 claims 1
- 238000009418 renovation Methods 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
- 230000002441 reversible effect Effects 0.000 claims 1
- 238000012552 review Methods 0.000 claims 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 claims 1
- 230000001523 saccharolytic effect Effects 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- BTIHMVBBUGXLCJ-OAHLLOKOSA-N seliciclib Chemical compound C=12N=CN(C(C)C)C2=NC(N[C@@H](CO)CC)=NC=1NCC1=CC=CC=C1 BTIHMVBBUGXLCJ-OAHLLOKOSA-N 0.000 claims 1
- 230000001953 sensory effect Effects 0.000 claims 1
- 229940076279 serotonin Drugs 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 238000002741 site-directed mutagenesis Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims 1
- 235000011888 snacks Nutrition 0.000 claims 1
- 229960000553 somatostatin Drugs 0.000 claims 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 230000007480 spreading Effects 0.000 claims 1
- 238000003892 spreading Methods 0.000 claims 1
- 239000005315 stained glass Substances 0.000 claims 1
- 230000037351 starvation Effects 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- 230000036561 sun exposure Effects 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 230000001839 systemic circulation Effects 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- WOXKDUGGOYFFRN-IIBYNOLFSA-N tadalafil Chemical compound C1=C2OCOC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@H]3N2C(=O)CN(C3=O)C)=C1 WOXKDUGGOYFFRN-IIBYNOLFSA-N 0.000 claims 1
- 239000008399 tap water Substances 0.000 claims 1
- 235000020679 tap water Nutrition 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 claims 1
- 230000008471 teeth growth Effects 0.000 claims 1
- 235000008070 tepary bean Nutrition 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 229940113082 thymine Drugs 0.000 claims 1
- 239000001585 thymus vulgaris Substances 0.000 claims 1
- 239000010936 titanium Substances 0.000 claims 1
- 229910052719 titanium Inorganic materials 0.000 claims 1
- 231100000167 toxic agent Toxicity 0.000 claims 1
- 239000003440 toxic substance Substances 0.000 claims 1
- 239000010891 toxic waste Substances 0.000 claims 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 claims 1
- 230000001228 trophic effect Effects 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 230000036325 urinary excretion Effects 0.000 claims 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 235000015192 vegetable juice Nutrition 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 235000013618 yogurt Nutrition 0.000 claims 1
- 229920002994 synthetic fiber Polymers 0.000 description 19
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 16
- 210000000963 osteoblast Anatomy 0.000 description 16
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 15
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 15
- 208000001132 Osteoporosis Diseases 0.000 description 15
- 229940112869 bone morphogenetic protein Drugs 0.000 description 15
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 15
- 239000007943 implant Substances 0.000 description 14
- 210000000349 chromosome Anatomy 0.000 description 13
- 206010017076 Fracture Diseases 0.000 description 11
- 230000008439 repair process Effects 0.000 description 11
- 235000014653 Carica parviflora Nutrition 0.000 description 10
- 241000243321 Cnidaria Species 0.000 description 10
- 108700020978 Proto-Oncogene Proteins 0.000 description 10
- 102000052575 Proto-Oncogene Human genes 0.000 description 10
- 210000002449 bone cell Anatomy 0.000 description 9
- 208000010392 Bone Fractures Diseases 0.000 description 8
- 239000003462 bioceramic Substances 0.000 description 7
- 230000011164 ossification Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- 208000020084 Bone disease Diseases 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 241001447056 Uristes Species 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 4
- 208000010191 Osteitis Deformans Diseases 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 239000000316 bone substitute Substances 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 230000022159 cartilage development Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 210000001564 haversian system Anatomy 0.000 description 4
- 210000001624 hip Anatomy 0.000 description 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 101800000504 3C-like protease Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241001609030 Brosme brosme Species 0.000 description 3
- 102000003964 Histone deacetylase Human genes 0.000 description 3
- 108090000353 Histone deacetylase Proteins 0.000 description 3
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- 208000027868 Paget disease Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002639 bone cement Substances 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 230000010072 bone remodeling Effects 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 238000003889 chemical engineering Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000027202 mammary Paget disease Diseases 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- 230000000399 orthopedic effect Effects 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 101800000607 p15 Proteins 0.000 description 3
- 239000003415 peat Substances 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 2
- 102100034111 Activin receptor type-1 Human genes 0.000 description 2
- 108010059616 Activins Proteins 0.000 description 2
- OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 2
- 102100028726 Bone morphogenetic protein 10 Human genes 0.000 description 2
- 102100028727 Bone morphogenetic protein 15 Human genes 0.000 description 2
- 102100024504 Bone morphogenetic protein 3 Human genes 0.000 description 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 2
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 2
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 2
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 2
- 102100037597 Brain-derived neurotrophic factor Human genes 0.000 description 2
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 2
- 102000055006 Calcitonin Human genes 0.000 description 2
- 108060001064 Calcitonin Proteins 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283153 Cetacea Species 0.000 description 2
- 108091029523 CpG island Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 2
- 208000034970 Heterotopic Ossification Diseases 0.000 description 2
- 101000799140 Homo sapiens Activin receptor type-1 Proteins 0.000 description 2
- 101000695367 Homo sapiens Bone morphogenetic protein 10 Proteins 0.000 description 2
- 101000695360 Homo sapiens Bone morphogenetic protein 15 Proteins 0.000 description 2
- 101000762375 Homo sapiens Bone morphogenetic protein 3 Proteins 0.000 description 2
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 2
- 101000899388 Homo sapiens Bone morphogenetic protein 5 Proteins 0.000 description 2
- 101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 2
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102100026818 Inhibin beta E chain Human genes 0.000 description 2
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- 101710111489 Neurotrophin 1 Proteins 0.000 description 2
- 108090000742 Neurotrophin 3 Proteins 0.000 description 2
- 102100029268 Neurotrophin-3 Human genes 0.000 description 2
- 102000003683 Neurotrophin-4 Human genes 0.000 description 2
- 108090000099 Neurotrophin-4 Proteins 0.000 description 2
- 102000043276 Oncogene Human genes 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 241000283080 Proboscidea <mammal> Species 0.000 description 2
- IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 2
- 101700032040 SMAD1 Proteins 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 241000276707 Tilapia Species 0.000 description 2
- 102100033663 Transforming growth factor beta receptor type 3 Human genes 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 108010079292 betaglycan Proteins 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 2
- 229960004015 calcitonin Drugs 0.000 description 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940009626 etidronate Drugs 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007941 heterotopic ossification Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 210000005170 neoplastic cell Anatomy 0.000 description 2
- 230000001613 neoplastic effect Effects 0.000 description 2
- 229940032018 neurotrophin 3 Drugs 0.000 description 2
- 229940097998 neurotrophin 4 Drugs 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000004072 osteoblast differentiation Effects 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 239000000583 progesterone congener Substances 0.000 description 2
- 102000016914 ras Proteins Human genes 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- 102100034134 Activin receptor type-1B Human genes 0.000 description 1
- 102100021886 Activin receptor type-2A Human genes 0.000 description 1
- 102100027647 Activin receptor type-2B Human genes 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 1
- 102000004152 Bone morphogenetic protein 1 Human genes 0.000 description 1
- 108091007914 CDKs Proteins 0.000 description 1
- 208000031968 Cadaver Diseases 0.000 description 1
- 235000021318 Calcifediol Nutrition 0.000 description 1
- 241000202252 Cerberus Species 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 108010066259 Collagraft Proteins 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 108091029430 CpG site Proteins 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- 206010067477 Cytogenetic abnormality Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 102100035784 Decorin Human genes 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 101150029707 ERBB2 gene Proteins 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 102100040897 Embryonic growth/differentiation factor 1 Human genes 0.000 description 1
- 102000016970 Follistatin Human genes 0.000 description 1
- 108010014612 Follistatin Proteins 0.000 description 1
- 208000034951 Genetic Translocation Diseases 0.000 description 1
- 108010050777 Growth Differentiation Factors Proteins 0.000 description 1
- 102000014015 Growth Differentiation Factors Human genes 0.000 description 1
- 102100040895 Growth/differentiation factor 10 Human genes 0.000 description 1
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 description 1
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 description 1
- 102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
- 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 1
- 102100035379 Growth/differentiation factor 5 Human genes 0.000 description 1
- 102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
- 102100035363 Growth/differentiation factor 7 Human genes 0.000 description 1
- 102100035970 Growth/differentiation factor 9 Human genes 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 101000799189 Homo sapiens Activin receptor type-1B Proteins 0.000 description 1
- 101000970954 Homo sapiens Activin receptor type-2A Proteins 0.000 description 1
- 101000937269 Homo sapiens Activin receptor type-2B Proteins 0.000 description 1
- 101000893552 Homo sapiens Embryonic growth/differentiation factor 1 Proteins 0.000 description 1
- 101000893563 Homo sapiens Growth/differentiation factor 10 Proteins 0.000 description 1
- 101000893545 Homo sapiens Growth/differentiation factor 11 Proteins 0.000 description 1
- 101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 1
- 101000893585 Homo sapiens Growth/differentiation factor 2 Proteins 0.000 description 1
- 101001023986 Homo sapiens Growth/differentiation factor 3 Proteins 0.000 description 1
- 101001023988 Homo sapiens Growth/differentiation factor 5 Proteins 0.000 description 1
- 101001023964 Homo sapiens Growth/differentiation factor 6 Proteins 0.000 description 1
- 101001023968 Homo sapiens Growth/differentiation factor 7 Proteins 0.000 description 1
- 101000886562 Homo sapiens Growth/differentiation factor 8 Proteins 0.000 description 1
- 101001075110 Homo sapiens Growth/differentiation factor 9 Proteins 0.000 description 1
- 101001054659 Homo sapiens Latent-transforming growth factor beta-binding protein 1 Proteins 0.000 description 1
- 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
- 101000799194 Homo sapiens Serine/threonine-protein kinase receptor R3 Proteins 0.000 description 1
- 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 102100027000 Latent-transforming growth factor beta-binding protein 1 Human genes 0.000 description 1
- 241001503485 Mammuthus Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 241000121185 Monodon monoceros Species 0.000 description 1
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
- 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 description 1
- 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 description 1
- 102100030590 Mothers against decapentaplegic homolog 6 Human genes 0.000 description 1
- 101710143114 Mothers against decapentaplegic homolog 6 Proteins 0.000 description 1
- 102100030608 Mothers against decapentaplegic homolog 7 Human genes 0.000 description 1
- 102100030607 Mothers against decapentaplegic homolog 9 Human genes 0.000 description 1
- 102100030173 Muellerian-inhibiting factor Human genes 0.000 description 1
- 108010056852 Myostatin Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 description 1
- 241000283201 Odobenidae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000027067 Paget disease of bone Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010050808 Procollagen Proteins 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 101700026522 SMAD7 Proteins 0.000 description 1
- 101700031501 SMAD9 Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 102100034136 Serine/threonine-protein kinase receptor R3 Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 102000043168 TGF-beta family Human genes 0.000 description 1
- 108091085018 TGF-beta family Proteins 0.000 description 1
- 102100033456 TGF-beta receptor type-1 Human genes 0.000 description 1
- 102100033455 TGF-beta receptor type-2 Human genes 0.000 description 1
- 108091005735 TGF-beta receptors Proteins 0.000 description 1
- 102100036034 Thrombospondin-1 Human genes 0.000 description 1
- 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 description 1
- 108010011702 Transforming Growth Factor-beta Type I Receptor Proteins 0.000 description 1
- 108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048049 Wrist fracture Diseases 0.000 description 1
- CVTZKFWZDBJAHE-UHFFFAOYSA-N [N].N Chemical compound [N].N CVTZKFWZDBJAHE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 108700025690 abl Genes Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 108010023082 activin A Proteins 0.000 description 1
- 108010023079 activin B Proteins 0.000 description 1
- 229940037127 actonel Drugs 0.000 description 1
- 229940062527 alendronate Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000000868 anti-mullerian hormone Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 208000016738 bone Paget disease Diseases 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000004221 bone function Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 108091008816 c-sis Proteins 0.000 description 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 1
- 229960004361 calcifediol Drugs 0.000 description 1
- 229960005084 calcitriol Drugs 0.000 description 1
- 235000020964 calcitriol Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000019827 calcium polyphosphate Nutrition 0.000 description 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 108010008846 chordin Proteins 0.000 description 1
- 102000006533 chordin Human genes 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000009164 estrogen replacement therapy Methods 0.000 description 1
- GWBBVOVXJZATQQ-UHFFFAOYSA-L etidronate disodium Chemical compound [Na+].[Na+].OP(=O)([O-])C(O)(C)P(O)([O-])=O GWBBVOVXJZATQQ-UHFFFAOYSA-L 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 230000008217 follicular development Effects 0.000 description 1
- 229940001490 fosamax Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000004545 gene duplication Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011507 gypsum plaster Substances 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 239000003501 hydroponics Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 108010067471 inhibin A Proteins 0.000 description 1
- 108010067479 inhibin B Proteins 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229950006344 nocodazole Drugs 0.000 description 1
- 102000045246 noggin Human genes 0.000 description 1
- 108700007229 noggin Proteins 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000008182 oocyte development Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000004819 osteoinduction Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 238000009522 phase III clinical trial Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000013354 porous framework Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000009929 raf Kinases Human genes 0.000 description 1
- 108010077182 raf Kinases Proteins 0.000 description 1
- 108010014186 ras Proteins Proteins 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229940089617 risedronate Drugs 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000110 selective laser sintering Methods 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 102000009310 vitamin D receptors Human genes 0.000 description 1
- 108050000156 vitamin D receptors Proteins 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
- B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
- B09C—RECLAMATION OF CONTAMINATED SOIL
- B09C1/00—Reclamation of contaminated soil
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
- C11D3/227—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin with nitrogen-containing groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W10/00—Technologies for wastewater treatment
- Y02W10/30—Wastewater or sewage treatment systems using renewable energies
- Y02W10/37—Wastewater or sewage treatment systems using renewable energies using solar energy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental & Geological Engineering (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Soil Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002629555A CA2629555A1 (fr) | 2008-05-14 | 2008-05-14 | Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002629555A CA2629555A1 (fr) | 2008-05-14 | 2008-05-14 | Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2629555A1 true CA2629555A1 (fr) | 2009-11-14 |
Family
ID=41297176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002629555A Abandoned CA2629555A1 (fr) | 2008-05-14 | 2008-05-14 | Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2629555A1 (fr) |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104012693A (zh) * | 2014-06-21 | 2014-09-03 | 浙江省新昌县澄潭茶厂 | 一种多功能变温茶叶杀青机 |
EP2968128A4 (fr) * | 2013-03-12 | 2016-11-16 | Applied Biores Inc | Suppositoire de chélation pour une administration de médicaments améliorée |
CN107935639A (zh) * | 2017-12-04 | 2018-04-20 | 山东庞大生物集团有限公司 | 高效含钙有机肥的制备方法 |
US10921492B2 (en) | 2018-01-09 | 2021-02-16 | Corning Incorporated | Coated articles with light-altering features and methods for the production thereof |
US11079725B2 (en) | 2019-04-10 | 2021-08-03 | Deere & Company | Machine control using real-time model |
CN113637481A (zh) * | 2021-07-23 | 2021-11-12 | 浙江大学 | 壳聚糖及其衍生物在消减土壤中抗生素抗性基因污染中的应用 |
US11178818B2 (en) | 2018-10-26 | 2021-11-23 | Deere & Company | Harvesting machine control system with fill level processing based on yield data |
US11234366B2 (en) | 2019-04-10 | 2022-02-01 | Deere & Company | Image selection for machine control |
US11240961B2 (en) | 2018-10-26 | 2022-02-08 | Deere & Company | Controlling a harvesting machine based on a geo-spatial representation indicating where the harvesting machine is likely to reach capacity |
US20220110251A1 (en) | 2020-10-09 | 2022-04-14 | Deere & Company | Crop moisture map generation and control system |
US11467605B2 (en) | 2019-04-10 | 2022-10-11 | Deere & Company | Zonal machine control |
US11474523B2 (en) | 2020-10-09 | 2022-10-18 | Deere & Company | Machine control using a predictive speed map |
US11477940B2 (en) | 2020-03-26 | 2022-10-25 | Deere & Company | Mobile work machine control based on zone parameter modification |
US11592822B2 (en) | 2020-10-09 | 2023-02-28 | Deere & Company | Machine control using a predictive map |
US11589509B2 (en) | 2018-10-26 | 2023-02-28 | Deere & Company | Predictive machine characteristic map generation and control system |
US11635765B2 (en) | 2020-10-09 | 2023-04-25 | Deere & Company | Crop state map generation and control system |
US11641800B2 (en) | 2020-02-06 | 2023-05-09 | Deere & Company | Agricultural harvesting machine with pre-emergence weed detection and mitigation system |
US11650587B2 (en) | 2020-10-09 | 2023-05-16 | Deere & Company | Predictive power map generation and control system |
US11675354B2 (en) | 2020-10-09 | 2023-06-13 | Deere & Company | Machine control using a predictive map |
US11672203B2 (en) | 2018-10-26 | 2023-06-13 | Deere & Company | Predictive map generation and control |
US11711995B2 (en) | 2020-10-09 | 2023-08-01 | Deere & Company | Machine control using a predictive map |
US11727680B2 (en) | 2020-10-09 | 2023-08-15 | Deere & Company | Predictive map generation based on seeding characteristics and control |
US11778945B2 (en) | 2019-04-10 | 2023-10-10 | Deere & Company | Machine control using real-time model |
US11825768B2 (en) | 2020-10-09 | 2023-11-28 | Deere & Company | Machine control using a predictive map |
US11844311B2 (en) | 2020-10-09 | 2023-12-19 | Deere & Company | Machine control using a predictive map |
US11845449B2 (en) | 2020-10-09 | 2023-12-19 | Deere & Company | Map generation and control system |
US11849672B2 (en) | 2020-10-09 | 2023-12-26 | Deere & Company | Machine control using a predictive map |
US11864483B2 (en) | 2020-10-09 | 2024-01-09 | Deere & Company | Predictive map generation and control system |
US11874669B2 (en) | 2020-10-09 | 2024-01-16 | Deere & Company | Map generation and control system |
US11889788B2 (en) | 2020-10-09 | 2024-02-06 | Deere & Company | Predictive biomass map generation and control |
US11889787B2 (en) | 2020-10-09 | 2024-02-06 | Deere & Company | Predictive speed map generation and control system |
US11895948B2 (en) | 2020-10-09 | 2024-02-13 | Deere & Company | Predictive map generation and control based on soil properties |
US11927459B2 (en) | 2020-10-09 | 2024-03-12 | Deere & Company | Machine control using a predictive map |
US11940593B2 (en) | 2020-07-09 | 2024-03-26 | Corning Incorporated | Display articles with diffractive, antiglare surfaces and methods of making the same |
US11946747B2 (en) | 2020-10-09 | 2024-04-02 | Deere & Company | Crop constituent map generation and control system |
US11957072B2 (en) | 2020-02-06 | 2024-04-16 | Deere & Company | Pre-emergence weed detection and mitigation system |
US11983009B2 (en) | 2020-10-09 | 2024-05-14 | Deere & Company | Map generation and control system |
US12013245B2 (en) | 2020-10-09 | 2024-06-18 | Deere & Company | Predictive map generation and control system |
-
2008
- 2008-05-14 CA CA002629555A patent/CA2629555A1/fr not_active Abandoned
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2968128A4 (fr) * | 2013-03-12 | 2016-11-16 | Applied Biores Inc | Suppositoire de chélation pour une administration de médicaments améliorée |
CN104012693B (zh) * | 2014-06-21 | 2016-01-13 | 浙江省新昌县澄潭茶厂 | 一种多功能变温茶叶杀青机 |
CN104012693A (zh) * | 2014-06-21 | 2014-09-03 | 浙江省新昌县澄潭茶厂 | 一种多功能变温茶叶杀青机 |
CN107935639A (zh) * | 2017-12-04 | 2018-04-20 | 山东庞大生物集团有限公司 | 高效含钙有机肥的制备方法 |
US12019209B2 (en) | 2018-01-09 | 2024-06-25 | Corning Incorporated | Coated articles with light-altering features and methods for the production thereof |
US10921492B2 (en) | 2018-01-09 | 2021-02-16 | Corning Incorporated | Coated articles with light-altering features and methods for the production thereof |
US11589509B2 (en) | 2018-10-26 | 2023-02-28 | Deere & Company | Predictive machine characteristic map generation and control system |
US11178818B2 (en) | 2018-10-26 | 2021-11-23 | Deere & Company | Harvesting machine control system with fill level processing based on yield data |
US11672203B2 (en) | 2018-10-26 | 2023-06-13 | Deere & Company | Predictive map generation and control |
US11240961B2 (en) | 2018-10-26 | 2022-02-08 | Deere & Company | Controlling a harvesting machine based on a geo-spatial representation indicating where the harvesting machine is likely to reach capacity |
US12010947B2 (en) | 2018-10-26 | 2024-06-18 | Deere & Company | Predictive machine characteristic map generation and control system |
US11778945B2 (en) | 2019-04-10 | 2023-10-10 | Deere & Company | Machine control using real-time model |
US11467605B2 (en) | 2019-04-10 | 2022-10-11 | Deere & Company | Zonal machine control |
US11650553B2 (en) | 2019-04-10 | 2023-05-16 | Deere & Company | Machine control using real-time model |
US11829112B2 (en) | 2019-04-10 | 2023-11-28 | Deere & Company | Machine control using real-time model |
US11234366B2 (en) | 2019-04-10 | 2022-02-01 | Deere & Company | Image selection for machine control |
US11079725B2 (en) | 2019-04-10 | 2021-08-03 | Deere & Company | Machine control using real-time model |
US11957072B2 (en) | 2020-02-06 | 2024-04-16 | Deere & Company | Pre-emergence weed detection and mitigation system |
US11641800B2 (en) | 2020-02-06 | 2023-05-09 | Deere & Company | Agricultural harvesting machine with pre-emergence weed detection and mitigation system |
US11477940B2 (en) | 2020-03-26 | 2022-10-25 | Deere & Company | Mobile work machine control based on zone parameter modification |
US11977206B2 (en) | 2020-07-09 | 2024-05-07 | Corning Incorporated | Display articles with diffractive, antiglare surfaces and thin, durable antireflection coatings |
US11971519B2 (en) | 2020-07-09 | 2024-04-30 | Corning Incorporated | Display articles with antiglare surfaces and thin, durable antireflection coatings |
US11940593B2 (en) | 2020-07-09 | 2024-03-26 | Corning Incorporated | Display articles with diffractive, antiglare surfaces and methods of making the same |
US11711995B2 (en) | 2020-10-09 | 2023-08-01 | Deere & Company | Machine control using a predictive map |
US11889787B2 (en) | 2020-10-09 | 2024-02-06 | Deere & Company | Predictive speed map generation and control system |
US11675354B2 (en) | 2020-10-09 | 2023-06-13 | Deere & Company | Machine control using a predictive map |
US11825768B2 (en) | 2020-10-09 | 2023-11-28 | Deere & Company | Machine control using a predictive map |
US11844311B2 (en) | 2020-10-09 | 2023-12-19 | Deere & Company | Machine control using a predictive map |
US11845449B2 (en) | 2020-10-09 | 2023-12-19 | Deere & Company | Map generation and control system |
US11849672B2 (en) | 2020-10-09 | 2023-12-26 | Deere & Company | Machine control using a predictive map |
US11864483B2 (en) | 2020-10-09 | 2024-01-09 | Deere & Company | Predictive map generation and control system |
US11874669B2 (en) | 2020-10-09 | 2024-01-16 | Deere & Company | Map generation and control system |
US11871697B2 (en) | 2020-10-09 | 2024-01-16 | Deere & Company | Crop moisture map generation and control system |
US11889788B2 (en) | 2020-10-09 | 2024-02-06 | Deere & Company | Predictive biomass map generation and control |
US11727680B2 (en) | 2020-10-09 | 2023-08-15 | Deere & Company | Predictive map generation based on seeding characteristics and control |
US11895948B2 (en) | 2020-10-09 | 2024-02-13 | Deere & Company | Predictive map generation and control based on soil properties |
US11927459B2 (en) | 2020-10-09 | 2024-03-12 | Deere & Company | Machine control using a predictive map |
US11650587B2 (en) | 2020-10-09 | 2023-05-16 | Deere & Company | Predictive power map generation and control system |
US11946747B2 (en) | 2020-10-09 | 2024-04-02 | Deere & Company | Crop constituent map generation and control system |
US11635765B2 (en) | 2020-10-09 | 2023-04-25 | Deere & Company | Crop state map generation and control system |
US11592822B2 (en) | 2020-10-09 | 2023-02-28 | Deere & Company | Machine control using a predictive map |
US11474523B2 (en) | 2020-10-09 | 2022-10-18 | Deere & Company | Machine control using a predictive speed map |
US11983009B2 (en) | 2020-10-09 | 2024-05-14 | Deere & Company | Map generation and control system |
US12013245B2 (en) | 2020-10-09 | 2024-06-18 | Deere & Company | Predictive map generation and control system |
US12013698B2 (en) | 2020-10-09 | 2024-06-18 | Deere & Company | Machine control using a predictive map |
US20220110251A1 (en) | 2020-10-09 | 2022-04-14 | Deere & Company | Crop moisture map generation and control system |
CN113637481A (zh) * | 2021-07-23 | 2021-11-12 | 浙江大学 | 壳聚糖及其衍生物在消减土壤中抗生素抗性基因污染中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2629555A1 (fr) | Innovations connexes ou chevauchant les domaines de la sante, de l'energie, des transports, de l'agriculture et des infrastructures | |
CN1827766B (zh) | 体外细胞的培养方法 | |
Chippaux | Snake venoms and envenomations | |
CN101072866A (zh) | 通过施用rna改变细胞性质的方法 | |
JP2002508175A (ja) | 食肉の工業的生産方法およびこの方法で生産される肉製品 | |
HU230800B1 (hu) | Új probiotikumok hobbiállat-eledel kompozíciókhoz | |
CN107028981A (zh) | 来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途 | |
CN102038721B (zh) | 一种松树提取液及其应用 | |
CN107809999A (zh) | 用于治疗组织病变的组合物 | |
CN109106728A (zh) | 人胎盘干细胞提取物冻干粉的制备方法及应用 | |
CN1704120A (zh) | 复合生物制品组合物及其制备方法 | |
CN108456248A (zh) | 水解水母i型、ii型和v型胶原蛋白及其用途 | |
Khan et al. | A Review-Benefits of Panchgavya therapy (Cowpathy) for health of humans | |
CA2639023A1 (fr) | Bioscience iii | |
KR20190135652A (ko) | 접골공진단을 포함하는 골 관련 질환의 예방 및 치료용 조성물 | |
CN103446628B (zh) | 一种复合种子细胞的组织工程神经的制备方法 | |
Haas | A study of the viability of bone after removal from the body | |
Wilson | Biobased Materials for Medical Applications | |
CN107854730A (zh) | 交联cga的海藻酸钠‑明胶共混膜关节补片的制备方法及其应用 | |
TW200418363A (en) | Cultivating method for pleurotus nebrodensis and a prophylaxis and ameliorate for disease containing pleurotus nebrodensis | |
KR101464267B1 (ko) | 파골세포 분화 억제활성을 갖는 조각자 추출물 및 이를 유효성분으로 함유하는 제품 | |
Campbell-McBride | Gut and Physiology Syndrome: Natural Treatment for Allergies, Autoimmune Illness, Arthritis, Gut Problems, Fatigue, Hormonal Problems, Neurological Disease and More | |
CN1393222B (zh) | 一种溶解在油脂中的甾醇化合物的组合物的新用途 | |
Morse | The Detox Miracle Sourcebook: Raw Foods and Herbs for Complete Cellular Regeneration | |
JP6711682B2 (ja) | 20−ヒドロキシエクジゾン含有植物抽出物及びその製造方法、並びに20−ヒドロキシエクジゾン含有植物抽出物の利用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |